syndrome	score	normalized_score
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	4.276748851000001	100.0
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	3.5	81.83786614408326
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	2.6119044000000002	61.072195048097754
MOWAT-WILSON SYNDROME; MOWS	2.528114661	59.11300263537499
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	2.312810826	54.07871508422134
D-BIFUNCTIONAL PROTEIN DEFICIENCY	2.2617481030000004	52.88475385855666
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	2.209248751	51.65720101809176
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	2.138349451	49.99941604006056
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	2.07619	48.545988374195495
LISSENCEPHALY 2; LIS2	2.051344822	47.96505227376981
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	2.039234048	47.68187515905174
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	2.030303	47.47304718455163
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	2.0	46.76449493947616
FOCAL CORTICAL DYSPLASIA OF TAYLOR	1.656400195	38.730359268412414
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	1.600844595	37.431344480882636
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	1.572716212	36.77363966865306
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	1.571157208	36.737186651318744
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	1.55236489	36.29778002131273
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	1.506469467	35.22464188299843
AICARDI SYNDROME; AIC	1.46767491	34.31753795074556
JOUBERT SYNDROME 2	1.4663897369999999	34.287487717618134
D-2-HYDROXYGLUTARIC ACIDURIA 1	1.417683488	33.14862615017745
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	1.408725398	32.93916587294127
HYDROLETHALUS SYNDROME 1	1.39945285	32.72235286093024
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	1.3931600510000002	32.57521307743493
HOLOPROSENCEPHALY 1; HPE1	1.361113218	31.825886097607555
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	1.3582939420000002	31.759965088490066
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	1.3511901	31.593861296860137
LEPTIN RECEPTOR DEFICIENCY; LEPRD	1.3505744000000002	31.579464847093025
MYOCLONUS AND ATAXIA	1.333333	31.176322165568283
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	1.3148284700000001	30.743644665797092
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	1.308351358	30.592195230123874
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	1.3018272	30.439645753236206
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	1.2956351	30.29486053867884
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	1.285164851	30.050042585491067
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	1.274171551	29.792994524381992
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	1.263378658	29.54063242934159
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	1.258090262	29.416977845351617
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	1.2521544649999998	29.278185570967487
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	1.251759633	29.268953511434514
#154780 MARSHALL SYNDROME; MRSHS	1.25	29.2278093371726
FUMARASE DEFICIENCY; FMRD	1.2117364519999998	28.333121588766392
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	1.1927404449999999	27.88895225215552
HOLOPROSENCEPHALY 7	1.1905474430000003	27.837674936689893
MYOPATHY, SCAPULOHUMEROPERONEAL	1.18883168	27.79755654162447
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	1.1848309430000001	27.70401031902913
PYRUVATE CARBOXYLASE DEFICIENCY	1.1803823279999999	27.59999170220154
JOUBERT SYNDROME 1	1.180064977	27.592571322584774
HARTSFIELD SYNDROME; HRTFDS	1.175828642	27.49351628925006
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.15917109	27.104025286146033
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	1.15105382	26.914225270227348
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	1.135577451	26.55235298033637
#613376 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C;;HMN IIC;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC;;DHMN2C	1.131111	26.44791731774291
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.1155914	26.08503418991156
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.1017596330000001	25.761616390973806
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	1.099915113	25.718487367870924
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	1.0984556	25.684360673719624
COSTELLO SYNDROME; CSTLO	1.0952965869999998	25.610495849993498
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	1.0909091	25.507906543189247
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	1.0873011	25.423543394318425
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.074023313	25.11307889283396
MARINESCO-SJOGREN SYNDROME; MSS	1.065463987	24.912942614127793
AMYOTROPHY, MONOMELIC	1.0588235	24.757673103774213
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	1.056471351	24.702674573770516
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	1.05442867	24.65491210112679
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	1.038749443	24.288296535278587
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0366029049999999	24.238105652559387
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	1.03633973	24.231952029581542
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	1.0357143	24.217328070546547
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	1.0349510899999999	24.199482505455165
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	1.0322581	24.136514346841636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	1.0317642759999999	24.124967631867136
#615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	1.02952381	24.072580501407604
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	1.02670183	24.006596266692952
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	1.0232558	23.926020340444815
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	1.020810603	23.86884613907855
THYROTROPIN-RELEASING HORMONE DEFICIENCY	1.020685855	23.865929250471197
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	1.02050631	23.861731084849243
300270 ADRENOMYODYSTROPHY	1.020074682	23.851638652138373
TRANSSEXUALITY	1.0188679	23.823421376772348
Pontine tegmental cap dysplasia	1.014663038	23.72510225291225
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	1.014466521	23.720507243786237
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	1.011807732	23.658338781418426
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	1.010175242	23.62016749624655
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	1.00891126	23.590612756325257
FRONTONASAL DYSPLASIA 1; FND1	1.007886845	23.566659631283546
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	1.007886132	23.566642959741102
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	1.007783812	23.564250488179994
STANKIEWICZ-ISIDOR SYNDROME; STISS	1.005959928	23.5216039811359
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	1.004271451	23.482123594074935
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	1.001688477	23.42172785679904
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	1.00127551	23.412071760208203
LIPOID PROTEINOSIS OF URBACH AND WIETHE	1.000915751	23.403659786240738
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	1.000844595	23.401995999039784
AGENESIS OF CEREBRAL WHITE MATTER	1.000844595	23.401995999039784
OCULOSKELETODENTAL SYNDROME; OCSKD	1.000843882	23.401979327497337
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.0	23.38224746973808
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	1.0	23.38224746973808
#609322 RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1;;BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIALMALIGNANT RHABDOID TUMOR, SOMATIC, INCLUDED;;RHABDOID TUMOR, INCLUDED; RDT, INCLUDED;;TERATOID TUMOR, ATYPICAL, INCLUDED;;AT/RT, INCLUDED	1.0	23.38224746973808
HAMAMY SYNDROME; HMMS	1.0	23.38224746973808
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	1.0	23.38224746973808
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2; CMAVM2	1.0	23.38224746973808
#613743 ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIALOR COMPLETE;;P450SCC DEFICIENCY	1.0	23.38224746973808
259660 OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION	1.0	23.38224746973808
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	23.38224746973808
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	1.0	23.38224746973808
TUBEROUS SCLEROSIS	0.965396346	22.573136268552886
TUBEROUS SCLEROSIS 2; TSC2	0.965396346	22.573136268552886
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.93015861	21.749198805127588
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.925435947	21.63877233014541
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.893000382	20.880355922494637
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.85034656	19.88301370096048
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.85034656	19.88301370096048
DANDY-WALKER SYNDROME	0.83472156	19.51766608424582
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.833333	19.485198430699242
#609452 MYOPATHY, MYOFIBRILLAR, 4; MFM4;;MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	0.8125	18.998076069162188
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.8106424799999999	18.9546430768422
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.7839084	18.329540202406424
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.7555556	17.666588016346434
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.7555556	17.666588016346434
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.75362885	17.62153627103412
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.75	17.53668560230356
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.75	17.53668560230356
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.7474208760000002	17.47637988668042
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.7473013610000001	17.473585357374073
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.7435686260000001	17.38630562386512
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.743343016	17.381030355013472
JOUBERT SYNDROME 6	0.715364077	16.726819879374766
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.7009157509999999	16.38898554531931
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.690995351	16.157024297520525
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.690995351	16.157024297520525
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.6900796	16.135611981017867
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.6882167509999999	16.09205438470111
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.683276633	15.976543323095402
PITUITARY ADENOMA, PROLACTIN-SECRETING	0.666666	15.588149391660405
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.66122048	15.460820895418998
ARIMA SYNDROME	0.6599895819999999	15.43203973377299
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.656636366	15.353634007441505
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.643088895	15.036863687930408
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.6428896119999999	15.032204003507893
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.642857	15.031441461653412
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.63780194	14.913242797759038
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.6374426799999999	14.904842491533058
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.633748666	14.818468142028381
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.6290876620000001	14.709483393042946
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.6226375430000002	14.558665114375687
CULLER-JONES SYNDROME; CJS	0.6175108819999999	14.438792258180227
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.611111	14.289148633479106
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.611111	14.289148633479106
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.585001051	13.678639344538867
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.5842487510000001	13.661048879767385
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.5833333	13.639643577938966
SPINOCEREBELLAR ATAXIA 1	0.5814809999999999	13.596332640950765
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.579675701	13.554120692975896
AICARDI-GOUTIERES SYNDROME 5	0.575375192	13.45356512729206
#100800 ACHONDROPLASIA; ACH	0.56446686	13.198503808985999
LISSENCEPHALY 1; LIS1	0.563494598	13.175770138296574
APROSENCEPHALY SYNDROME	0.5625	13.15251420172767
NEMALINE MYOPATHY 2; NEM2	0.5612376900000001	13.122998556924149
NEMALINE MYOPATHY 3; NEM3	0.5612376900000001	13.122998556924149
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.5588235	13.066549368905179
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.558218028	13.052392072765178
HOLOPROSENCEPHALY 2; HPE2	0.5566691180000001	13.01617507583683
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.556471351	13.011550838901481
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5526316	12.921768830797307
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.552227201	12.912313073302792
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.549379346	12.845723822934863
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.548158726	12.81718298402835
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.5459174299999999	12.764776446303413
JOUBERT SYNDROME 5	0.541122395	12.652657751307359
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.5388885600000001	12.600425668530798
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.5388774510000001	12.600165915143657
SECKEL SYNDROME 1; SCKL1	0.537891656	12.577115812499226
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.536458395	12.5436029491085
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.52770538	12.33893778627217
MELANOSIS, NEUROCUTANEOUS; NCMS	0.522940193	12.227517004598594
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.5224321630000001	12.215638121416543
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.52135409	12.1904303517401
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.5190494910000001	12.13654364760359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.5158370830000001	12.061430328773822
PAPILLOMA OF CHOROID PLEXUS	0.513717691	12.011874180544439
GLUTAMINE DEFICIENCY, CONGENITAL	0.512908421	11.992951629134604
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.511949393	11.970527399108194
BRANCHIOOTORENAL SYNDROME 1	0.50847458	11.889278461631132
FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	0.50847458	11.889278461631132
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.50555556	11.821025213622018
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.502604228	11.75201643843266
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.502604228	11.75201643843266
ENCEPHALOMALACIA, MULTILOCULAR	0.502120105	11.74069655464087
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.501760346	11.732284580673403
ACTH DEFICIENCY, ISOLATED; IAD	0.500915751	11.712536051371698
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.500915751	11.712536051371698
MECKEL SYNDROME, TYPE 1; MKS1	0.50037705	11.699940011277505
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.5	11.69112373486904
SUDANOPHILIC CEREBRAL SCLEROSIS	0.5	11.69112373486904
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	11.69112373486904
MYOCLONIC EPILEPSY OF LAFORA	0.5	11.69112373486904
TRICHOHEPATOENTERIC SYNDROME 1	0.5	11.69112373486904
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.5	11.69112373486904
IMMUNODEFICIENCY 36; IMD36	0.5	11.69112373486904
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.5	11.69112373486904
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.5	11.69112373486904
#615106 COWDEN SYNDROME 3; CWS3	0.5	11.69112373486904
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.49427699500000005	11.557307015688492
#608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY	0.49420902	11.555717607416735
JOUBERT SYNDROME 4	0.4939786	11.550329869954759
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.49122363300000005	11.485912549789798
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.47878822600000004	11.195144785928884
JOUBERT SYNDROME 3; JBTS3	0.47601449500000004	11.1302887212724
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.463062023	10.827430815623545
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.457679846	10.701583421083614
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.45149678600000004	10.557009582043374
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.45084388200000003	10.541743219141393
SMITH-KINGSMORE SYNDROME; SKS	0.446204446	10.43326277846938
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.44571241300000003	10.421757941100104
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.44087983199999997	10.308761336240549
OROFACIODIGITAL SYNDROME I; OFD1	0.438800866	10.26015043874738
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.4385302	10.253821659353733
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.435821806	10.19049332060018
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.4326654930000001	10.116691628942231
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.43203298599999995	10.101902193741886
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.426930021	9.982583403282474
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.42582477999999996	9.956740384706773
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.42038447	9.829533709974683
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.419361505	9.805614489191804
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.419297415	9.804115920951467
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.4166663	9.742594538900127
LISSENCEPHALY 5; LIS5	0.416356736	9.735356236844407
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.41566725099999996	9.719234527947732
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.41101653800000004	9.610490405671007
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.409524	9.575591512797017
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.40623386300000003	9.498660715253676
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.40367761	9.438889775012417
PALLISTER-HALL SYNDROME	0.401858033	9.396343975308172
JOUBERT SYNDROME 7	0.398334177	9.31394830226845
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.397374358	9.291505576884292
#256520 NEU-LAXOVA SYNDROME; NLS	0.39476948999999995	9.23059790868229
ANEURYSM, INTRACRANIAL BERRY, 2	0.392857	9.185879594218893
WEBB-DATTANI SYNDROME; WEDAS	0.39007446300000004	9.12081762549119
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.3888886	9.093089483359982
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.38682359299999997	9.044804978659242
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.38559109999999996	9.015986522328522
MICROPHTHALMIA, SYNDROMIC 3	0.37941287200000007	8.87152566630806
CHARGE SYNDROME	0.377360085	8.823526892671396
GLYCOGEN STORAGE DISEASE II	0.37679381	8.81028611048547
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.37342639099999997	8.731548286093172
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.37203189999999997	8.698941952436849
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.36824055099999997	8.610291691874705
CANAVAN DISEASE	0.36781579999999997	8.600360058879685
JOUBERT SYNDROME 26	0.36668941199999994	8.574022575916743
ULNAR-MAMMARY SYNDROME; UMS	0.366667	8.573498532986452
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.36626817300000003	8.56417306137484
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.363853891	8.507721722189105
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.36141321299999996	8.450653185199158
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.361178363	8.445161864380891
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.36001749	8.418018044613953
RHYNS SYNDROME; RHYNS	0.3505744	8.197217377354946
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.35015374600000004	8.187381541427811
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.34937904599999997	8.169267314313004
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.348867336	8.157302384460262
MARSHALL-SMITH SYNDROME; MRSHSS	0.348794955	8.155609954006158
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.348757728	8.154739503079602
VISCERAL STEATOSIS, CONGENITAL	0.345359851	8.075289502193868
CHROMOSOME 3q13.31 DELETION SYNDROME	0.34507009	8.068514238784791
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.34354950700000003	8.032959590780516
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.34285681	8.016762778104969
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.342339726	8.004672192054327
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.342339726	8.004672192054327
MYOPATHY, DISTAL 3	0.34152972	7.985732431310353
AL KAISSI SYNDROME; ALKAS	0.340796968	7.968599042712408
SPINOCEREBELLAR ATAXIA 42	0.33705047	7.88099749933153
Boucher-Neuhauser syndrome	0.33705047	7.88099749933153
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.336297287	7.86338638803553
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.335524261	7.845311302802989
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.33533016700000007	7.840772948862599
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.335093346	7.8352355416345665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.335092633	7.83521887009212
PAINE SYNDROME	0.33460850999999997	7.823898986300327
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.334177595	7.813823225131906
PARKINSON DISEASE, LATE-ONSET; PD	0.3333333	7.794081710504444
#181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2;;EMD2;;EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;;SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;;MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMALDOMINANT;;HAUPTMANN-THANNHAUSER MUSCULAR DYSTROPHYEMERY-DREIFUSS MUSCULAR DYSTROPHY, ATYPICAL, AUTOSOMAL RECESSIVE,INCLUDED;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE, INCLUDED;EDMD3, INCLUDED	0.3333333	7.794081710504444
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.3333333	7.794081710504444
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.333333	7.7940746958302025
SPINOCEREBELLAR ATROPHY WITH PUPILLARY PARALYSIS	0.333333	7.7940746958302025
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.333333	7.7940746958302025
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.333333	7.7940746958302025
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.333333	7.7940746958302025
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.333333	7.7940746958302025
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	7.7940746958302025
#170400 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1;;HYPOKALEMIC PERIODIC PARALYSIS; HOKPP	0.333333	7.7940746958302025
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.333333	7.7940746958302025
PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES	0.333333	7.7940746958302025
POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS	0.333333	7.7940746958302025
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.333333	7.7940746958302025
PROLACTIN DEFICIENCY, ISOLATED	0.333333	7.7940746958302025
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.333333	7.7940746958302025
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.333333	7.7940746958302025
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.333333	7.7940746958302025
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.333333	7.7940746958302025
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.333333	7.7940746958302025
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.32780546099999996	7.664828411033573
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.320592143	7.496164824479658
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.318624272	7.450151577769137
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.317954691	7.434495269126103
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.317689491	7.428294297097128
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.3173203	7.419661781771528
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.31702022	7.4126452369508105
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.316587561	7.402528697142801
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.31558004	7.378970591789842
COCKAYNE SYNDROME A; CSA	0.312810826	7.314220144745177
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.31104800000000005	7.273001310967091
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.309524	7.23736676582321
HUNTINGTON DISEASE-LIKE 1	0.30882350000000003	7.220987501470658
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.30882350000000003	7.220987501470658
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.308415613	7.211450186696967
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.3055556	7.1445766549643
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.30186071999999997	7.0581820564333135
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.30000000000000004	7.014674240921424
MICROHYDRANENCEPHALY; MHAC	0.29874122999999997	6.985241369273941
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.29758007300000006	6.958090908948724
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.2949005230000001	6.895437007741188
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.29399584300000003	6.874283556100264
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.29332024199999995	6.85848648632746
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.289061831	6.758915266497606
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.287474646	6.72180331404735
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.287474646	6.72180331404735
PANHYPOPITUITARISM, X-LINKED	0.28571399999999997	6.680635453568745
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.28509293300000005	6.666113511279459
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.285071951	6.6656229049630475
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.284806913	6.659425720858163
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.28389239800000005	6.638042304813377
CRANIOTELENCEPHALIC DYSPLASIA	0.2834744619999999	6.628270021834862
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.282735805	6.6109985610656095
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.281024143	6.570976056597062
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.281003343	6.570489705849692
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.278294332	6.507146940249449
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.27712602000000003	6.479829179943584
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.277027	6.4775138697991315
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.27514158	6.4334285127747375
PROPIONIC ACIDEMIA	0.274336523	6.414604470773493
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.273492106	6.394860103511839
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.273325382	6.390961721684694
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.271225928	6.341871768705362
#270685 SPASTIC PARAPLEGIA 17; SPG17;;SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;;SILVER SYNDROME;;SILVER SPASTIC PARAPLEGIA SYNDROME	0.27	6.313206816829281
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.27	6.313206816829281
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.269836238	6.309377693219142
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.269271463	6.296171984404421
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.2678571	6.26310099872638
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.267741043	6.260387325231783
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.2672414	6.248704548959262
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.26371769100000003	6.16631231310992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.263605012	6.163677624847277
SEPTOOPTIC DYSPLASIA	0.263223132	6.154748412183532
ADAMS-OLIVER SYNDROME 1; AOS1	0.262826908	6.145483804562083
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.26191419	6.124142406415998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.261707058	6.119299194733097
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.26132801	6.1104362005941875
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.26060208	6.09346232568848
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.259793046	6.074545292489049
BASAL CELL NEVUS SYNDROME	0.25975585500000004	6.073675683323402
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.25971896800000005	6.072813182360986
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.259696513	6.072288133994053
MYOTILINOPATHY	0.25952381	6.068249949709286
#300696 MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMAEMERY-DREIFUSS MUSCULAR DYSTROPHY 6, X-LINKED, INCLUDED; EDMD6, INCLUDED	0.25952381	6.068249949709286
PHELAN-MCDERMID SYNDROME; PHMDS	0.259070883	6.057659498509559
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.259006013	6.056142692116198
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.25847458	6.043716594196613
PETTIGREW SYNDROME	0.258371693	6.041310864901194
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.25819672	6.0372196029146705
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.2572869	6.015945966521754
PORPHYRIA, ACUTE HEPATIC	0.25724638	6.01499851785428
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.25724638	6.01499851785428
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.256471311	5.996875662690157
LOWE OCULOCEREBRORENAL SYNDROME	0.256455186	5.996498623949708
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.255031973	5.96322070538156
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.254997381	5.962411866677087
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.25469484	5.955337778145344
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.254428112	5.949101078042236
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.2533557	5.92402567526872
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.252191261	5.896798474407305
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.251538005	5.881523880954214
HYDROCEPHALUS, NORMAL-PRESSURE	0.250843882	5.865293725193778
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.250843882	5.865293725193778
MARDEN-WALKER SYNDROME	0.25031813599999997	5.853000602115552
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.250116663	5.848289710571082
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.250069312	5.8471825377711415
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.25	5.84556186743452
POLYCYSTIC KIDNEYS	0.25	5.84556186743452
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.25	5.84556186743452
HYPERLIPOPROTEINEMIA, TYPE IV	0.25	5.84556186743452
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.25	5.84556186743452
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.25	5.84556186743452
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.25	5.84556186743452
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.25	5.84556186743452
DYSTONIA 6, TORSION	0.25	5.84556186743452
ANEURYSM, INTRACRANIAL BERRY, 3	0.25	5.84556186743452
SPINOCEREBELLAR ATAXIA 40; SCA40	0.25	5.84556186743452
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	5.84556186743452
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.25	5.84556186743452
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.25	5.84556186743452
HYPERPARATHYROIDISM 2	0.25	5.84556186743452
PAPILLON-LEFEVRE SYNDROME	0.25	5.84556186743452
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.25	5.84556186743452
#614042 MOYAMOYA DISEASE 5; MYMY5	0.25	5.84556186743452
MUSCULAR ATROPHY, MALIGNANT NEUROGENIC	0.25	5.84556186743452
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.24957617299999998	5.835651839636163
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.249334238	5.829994855594572
COACH SYNDROME	0.248768233	5.816760386615463
OROFACIODIGITAL SYNDROME VI	0.24869707700000002	5.815096599414506
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.24767947999999998	5.7913028945360425
HOLOPROSENCEPHALY 3; HPE3	0.24765882700000003	5.790819980979052
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.24455158999999999	5.718165796497924
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.24317444600000002	5.685965074688459
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.242857	5.67854247375818
CARNEY COMPLEX, TYPE 1; CNC1	0.242857	5.67854247375818
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.242857	5.67854247375818
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.242857	5.67854247375818
NEMALINE MYOPATHY 1; NEM1	0.24209910999999998	5.66082130222334
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.23983881	5.607970408267493
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.23852036	5.577142084091015
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3	0.236111	5.520805832327327
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.23529324299999999	5.501684835783217
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.23513541600000007	5.497994485811812
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.233156301	5.45171832911074
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.23290722800000002	5.44589444258671
VICI SYNDROME; VICIS	0.232663893	5.440204723398661
RIGID SPINE MUSCULAR DYSTROPHY 1	0.23184008	5.420942123963874
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.22973512100000001	5.371723451712222
COHEN SYNDROME	0.22938008599999998	5.363421935481803
XIA-GIBBS SYNDROME	0.229082207	5.356456854987765
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.228772511	5.3492154664753775
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.2285714	5.34451303930449
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.2283557	5.339469488525268
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.22788718	5.328514437940745
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.22782748200000003	5.327118564531299
ADAMS-OLIVER SYNDROME 2; AOS2	0.225822183	5.28023016706248
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.22321981299999996	5.2193809077146565
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.222899605	5.211893725016868
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.222805547	5.209694437584359
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.222040213	5.191799208599353
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.22086050000000002	5.164214867290087
SCHIZENCEPHALY	0.21880695	5.116198252998607
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.218085995	5.099340704774061
CORNELIA DE LANGE SYNDROME 3	0.217529628	5.086331593896066
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.21732030000000002	5.0814370347977205
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.21689992800000002	5.071607792664372
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.215841151	5.046851206835105
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.21504809	5.028307658274507
YUNIS-VARON SYNDROME	0.21218588999999996	4.961382989566621
SPINOCEREBELLAR ATAXIA 2; SCA2	0.211111	4.936249645583875
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.208162131	4.867298460870036
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.207083651	4.842081174618873
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.20672677	4.833736494759626
COLE-CARPENTER SYNDROME 1; CLCRP1	0.20555556	4.806350972700594
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.20490485600000002	4.791136050743046
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.20408163	4.771887176687524
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.201760346	4.717610339751979
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.20175963300000002	4.717593668209534
Jawad syndrome	0.201688477	4.715929881008576
LAMBOTTE SYNDROME	0.20127551000000002	4.706273784417742
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.200915751	4.697861810450276
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.200915751	4.697861810450276
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.200843882	4.696181351706874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.200843882	4.696181351706874
CHROMOSOME 1P36 DELETION SYNDROME	0.20019447800000004	4.680996826671036
HOLOPROSENCEPHALY 4	0.2	4.676449493947616
#613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	0.2	4.676449493947616
CRANIOSYNOSTOSIS 4; CRS4	0.2	4.676449493947616
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.2	4.676449493947616
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.2	4.676449493947616
HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	0.2	4.676449493947616
ARTERIOVENOUS MALFORMATIONS OF THE BRAIN	0.2	4.676449493947616
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.19577608999999999	4.577684985037714
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.1944129	4.545810539109442
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.1944129	4.545810539109442
BAND HETEROTOPIA; BH	0.194337583	4.544049458376764
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.19404859000000002	4.537292152533742
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.19272052	4.506238891136607
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.192667518	4.504999585256217
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.19259589200000002	4.503324808398949
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.192348523	4.497540765224606
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.19131039100000002	4.473266905894353
JOUBERT SYNDROME 21	0.190807607	4.461510685982527
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.187657433	4.387852537941793
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.18730150999999998	4.37953025827562
VAN MALDERGEM SYNDROME 1; VMLDS1	0.186720325	4.365940846779921
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.18659203199999996	4.362941068105286
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.18649213500000003	4.360605251729803
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.18577850299999998	4.343918931703477
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.18496348	4.324861862223949
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.184913913	4.323702874363618
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.18313253300000001	4.282050206365976
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.18250780000000003	4.267442544757464
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.182292	4.262396655753494
WHITE-SUTTON SYNDROME; WHSUS	0.18148722700000003	4.243579254310531
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.17900518199999998	4.185543463889504
MECKEL SYNDROME, TYPE 4; MKS4	0.17881809999999998	4.181169066268371
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.17862855099999997	4.176736984642729
MYOPATHY, CENTRONUCLEAR, 5	0.17849728	4.17366757363513
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.17777769999999998	4.156842176000855
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.17758054299999998	4.152232202236464
STORMORKEN SYNDROME; STRMK	0.17619081	4.1197371213136025
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.17619081	4.1197371213136025
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.175701492	4.108295766746204
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.17557826	4.105414325626015
#614483 PORENCEPHALY 2; POREN2	0.174286673	4.075214118763318
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.17371851099999996	4.061929214276415
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.1732902	4.051914340480406
VASCULAR HYALINOSIS	0.17315999999999998	4.048869971859846
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.17313831100000002	4.048362834294475
NEUROFIBROMATOSIS, TYPE I	0.173138311	4.048362834294474
CURRY-JONES SYNDROME	0.17302047200000004	4.045607493634889
WEAVER SYNDROME	0.17295762800000003	4.0441380596749
ICHTHYOSIS AND MALE HYPOGONADISM	0.172508976	4.033647567583107
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.17222256	4.026950517791814
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.17213982800000002	4.025016057694149
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.172038308	4.02264229193102
DYSTROPHIA MYOTONICA 2	0.17202381	4.022303296107204
COFFIN-SIRIS SYNDROME 6; CSS6	0.17171117700000002	4.014993233933998
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.17136184000000002	4.006824949749662
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.170045821	3.9760534678167847
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.1700227	3.975512846873036
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.1700227	3.975512846873036
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.169702856	3.968034175313326
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.169702143	3.9680175037708794
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.169003903	3.95169108329761
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.167582751	3.9184613555414964
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.167582751	3.9184613555414964
ARTERIAL TORTUOSITY SYNDROME	0.167511595	3.9167975683405403
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.16747202999999997	3.915872449719399
FRYNS SYNDROME; FRNS	0.16728459599999998	3.911489821547156
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.16716125	3.9086057148507547
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.166667	3.8970490390388366
SPEECH-LANGUAGE DISORDER 1	0.166667	3.8970490390388366
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.166667	3.8970490390388366
HYPERPROLACTINEMIA; HPRL	0.166667	3.8970490390388366
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.166667	3.8970490390388366
#607398 GLUCOCORTICOID DEFICIENCY 2; GCCD2;;FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2	0.166667	3.8970490390388366
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.166667	3.8970490390388366
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.166667	3.8970490390388366
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.166667	3.8970490390388366
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.166667	3.8970490390388366
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.166067833	3.8830391679691356
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.165561386	3.8711972988848293
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.16466038100000002	3.8501297770033585
LISSENCEPHALY 3; LIS3	0.164335581	3.842535223025187
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.16110028200000004	3.766886661168592
AMYLOIDOSIS VI	0.1610501	3.7657132932260646
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.16094228199999996	3.7631922660683714
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.160773451	3.759244617845809
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.16056118000000003	3.754281244793161
ANEURYSM, INTRACRANIAL BERRY, 1	0.16025640000000002	3.747154803409334
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.16009839999999997	3.7434604083091143
#173100 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2;;IGHD II;;GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL DOMINANT;;PITUITARY DWARFISM DUE TO ISOLATED GROWTH HORMONE DEFICIENCY, AUTOSOMALDOMINANT	0.16009839999999997	3.7434604083091143
CYSTINOSIS, NEPHROPATHIC; CTNS	0.15952241	3.72999246758902
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.15915623	3.721430356210552
HEART AND BRAIN MALFORMATION SYNDROME	0.15671588300000003	3.6643695587445193
GLYCEROL KINASE DEFICIENCY; GKD	0.156572328	3.661012920209001
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.156461223	3.6584150356038756
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.15631017699999997	3.65488324065256
Growth hormone deficiency, isolated, type IA	0.1539681	3.600120216645379
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.1539681	3.600120216645379
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.1539371	3.599395366973818
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.152838773	3.5737140132571223
GENITOPATELLAR SYNDROME; GTPTS	0.15201864199999998	3.5545375072575185
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.15177337999999999	3.548802730478596
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.15160479300000002	3.5448607875244154
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.1509522	3.5296016965013965
JOUBERT SYNDROME 23; JBTS23	0.150843882	3.5270689782199693
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.15065360000000003	3.5226197574069333
FETAL AKINESIA SYNDROME, X-LINKED	0.14989924999999998	3.504981359028135
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.149335243	3.491793607779471
JOUBERT SYNDROME 10	0.148697077	3.4768718524406985
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.14841255999999997	3.4702192055373504
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.148303223	3.4676626607457526
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.14774153100000004	3.4545290393999806
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.14764829000000002	3.4523488552636548
VAN MALDERGEM SYNDROME 2; VMLDS2	0.14728582499999998	3.4438736089345348
#300867 KABUKI SYNDROME 2; KABUK2	0.147248838	3.4430087697473724
SECKEL SYNDROME 10; SCKL10	0.14710881	3.4397346003986797
PITUITARY DWARFISM IV	0.14693863	3.4357554095242793
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.14625949500000002	3.4198757068889196
#612885 PREMATURE OVARIAN FAILURE 10; POF10MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED;MENOQ3, INCLUDED	0.1458333	3.4099103099285544
PRECOCIOUS PUBERTY, CENTRAL	0.1458333	3.4099103099285544
PREMATURE OVARIAN FAILURE 7	0.1458333	3.4099103099285544
OVARIAN DYSGENESIS 8; ODG8	0.1458333	3.4099103099285544
ANDROGEN INSENSITIVITY SYNDROME	0.1458333	3.4099103099285544
PREMATURE OVARIAN FAILURE 14; POF14	0.1458333	3.4099103099285544
46,XY SEX REVERSAL 3	0.1458333	3.4099103099285544
46,XY SEX REVERSAL 1; SRXY1	0.1458333	3.4099103099285544
46,XX SEX REVERSAL 1; SRXX1	0.1458333	3.4099103099285544
SPERMATOGENIC FAILURE 28; SPGF28	0.1458333	3.4099103099285544
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.14544014	3.4007173455133515
DUBOWITZ SYNDROME	0.144977105	3.3898905465562015
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.14413251	3.3701420172544982
#615041 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 10; MDDGA10	0.1435898	3.3574522377301963
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.143208937	3.3485468048121305
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.143208937	3.3485468048121305
LOEYS-DIETZ SYNDROME 3; LDS3	0.14285699999999998	3.3403177267843724
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.1427788	3.3384892350322395
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.142729375	3.337333567451047
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.142426555	3.3302529552722615
NEMALINE MYOPATHY 4	0.1420833	3.3222268819170364
WAISMAN SYNDROME; WSMN	0.14149312800000002	3.308427334163327
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.14094220000000002	3.2955453993293187
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.14068080100000002	3.2894333032229763
#610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	0.13990718000000002	3.27134430555319
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.13968488	3.2661464319406677
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.13843264600000002	3.2368663866626477
HYPOTONIA-CYSTINURIA SYNDROME	0.137670862	3.2190541646561606
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.137540391	3.216003459446536
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.13694176200000002	3.202006168025975
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.13601231300000002	3.1802735614974744
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.13516050000000002	3.1603562591335335
KRABBE DISEASE	0.134038591	3.1341235052570076
RADICULONEUROPATHY, FATAL NEONATAL	0.13319672	3.114438669197411
Fabry disease	0.133162131	3.11362990063968
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.133096673	3.1120993454848067
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.13201717200000002	3.086858185958977
OROFACIODIGITAL SYNDROME XIV; OFD14	0.131483552	3.074380951064175
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.13113122	3.0661426370486673
#602398 DESMOSTEROLOSIS	0.130168643	3.043635423425989
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.13012136700000002	3.04253000429461
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.12955470000000002	3.0292800562676763
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.12849654600000002	3.004538037578583
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.12841547600000003	3.0026424387762116
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.12788466	2.9902307677033146
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.12769640000000002	2.9858288257946617
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.127560588	2.9826532360013016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.127502503	2.9812950781570215
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.127293351	2.976404634334231
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.12687988	2.966736753090671
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.126807642	2.965047666297952
OCULOECTODERMAL SYNDROME; OES	0.12675963299999998	2.963925107979177
BECKWITH-WIEDEMANN SYNDROME	0.126736	2.963372515324725
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.12589054	2.94360376037896
TARP SYNDROME; TARPS	0.125821812	2.9419967452748605
TENORIO SYNDROME; TNORS	0.125795646	2.9413849253875672
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.125447322	2.933240327419918
OPTIC ATROPHY 11; OPA11	0.125273217	2.929169361224199
#611283 ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;;IBD DEFICIENCY;;ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8, DEFICIENCY OF;;ACAD8 DEFICIENCY	0.125	2.92278093371726
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.125	2.92278093371726
CARNITINE DEFICIENCY, MYOPATHIC	0.125	2.92278093371726
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.12495727799999999	2.9217819973408576
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.12472571999999998	2.9163676508812597
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.12435657300000001	2.907736164374549
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.124260833	2.905497548001796
BETHLEM MYOPATHY 1	0.12364033	2.890988793300081
NEMALINE MYOPATHY 6	0.1232558	2.8819976176805424
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.12216116000000002	2.856402474310269
MYOPATHY, SPHEROID BODY	0.12180216	2.848008247468633
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.120833182	2.8253513640799004
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.12055464100000002	2.818838449487433
ALLAN-HERNDON-DUDLEY SYNDROME	0.12050631	2.8177083620849728
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.12050031300000001	2.8175681387468967
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.12001266099999999	2.8061657390037835
MYXEDEMA	0.11984126	2.802157998405223
COFFIN-SIRIS SYNDROME 4; CSS4	0.11950473800000001	2.7942893577222123
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.119498898	2.7941528053969886
NONAKA MYOPATHY	0.11930771999999999	2.789682634090219
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.1192983	2.789462373319054
ANTERIOR SEGMENT DYSGENESIS 3	0.1192308	2.787884071614847
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.118642733	2.7741337434920603
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.11818416999999999	2.7634115099455947
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.118029087	2.7597853208612455
DE SANCTIS-CACCHIONE SYNDROME	0.11694857499999999	2.7345205218832236
TURNPENNY-FRY SYNDROME; TPFS	0.11668811700000001	2.728430428471751
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.11619808000000001	2.716972262068423
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.11611291000000001	2.714980796051426
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.11611291000000001	2.714980796051426
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.11586439999999999	2.7091700737327207
GITELMAN SYNDROME	0.115610991	2.703244801783662
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.11556121	2.7020808101223706
CITRULLINEMIA, CLASSIC	0.11534510800000002	2.697027859679666
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.115345108	2.6970278596796655
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.115345108	2.6970278596796655
PREMATURE OVARIAN FAILURE 1	0.11519262999999999	2.693462581349974
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.11509344299999999	2.6911433663701936
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.11482846999999999	2.6849477021113946
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.11430485000000001	2.672704289691291
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.1142857	2.672256519652245
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.114098528	2.667880017628839
MECKEL SYNDROME 12; MKS12	0.11406489	2.6670934855884525
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.11279142500000001	2.6373170118144027
WITTEVEEN-KOLK SYNDROME	0.11273350800000002	2.635962782187698
MYASTHENIA GRAVIS; MG	0.11268279	2.6347768813605272
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.11238403800000002	2.627791388164449
NEMALINE MYOPATHY 10	0.11217758	2.622963936116341
GLYCOGEN STORAGE DISEASE 0, LIVER	0.112026751	2.6194372151127276
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.112026751	2.6194372151127276
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.112026751	2.6194372151127276
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.112026751	2.6194372151127276
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.11195488199999999	2.617756756369325
611961 STEVENSON-CAREY SYNDROME	0.11193558800000002	2.6173056192866446
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.11193296300000002	2.6172442408870364
NEMALINE MYOPATHY 7; NEM7	0.11173766	2.6126776178094535
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.11142860000000002	2.605451100406457
PSEUDO-TORCH SYNDROME 2	0.111312331	2.6027324698753977
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.11111099999999999	2.5980248986100674
OVARIAN DYSGENESIS 1	0.11111099999999999	2.5980248986100674
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.11111099999999999	2.5980248986100674
#615724 PREMATURE OVARIAN FAILURE 9; POF9	0.11111099999999999	2.5980248986100674
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.11111099999999999	2.5980248986100674
HYPERGONADOTROPIC HYPOGONADISM	0.11111099999999999	2.5980248986100674
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.11111099999999999	2.5980248986100674
PREMATURE OVARIAN FAILURE 8; POF8	0.11111099999999999	2.5980248986100674
LISSENCEPHALY 8; LIS8	0.110897108	2.5930236229342705
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.11086317600000001	2.5922302165131272
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.109875677	2.5691402705190085
COFFIN-SIRIS SYNDROME 3; CSS3	0.10962686800000002	2.5633225569083105
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.10955458	2.561632301003218
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.10941197700000002	2.558297922367291
WARBURG MICRO SYNDROME 2; WARBM2	0.10938442999999999	2.5576538115962415
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.10805556000000001	2.5265818444011314
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.107675665	2.517699045498615
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.10757045	2.5152388823310865
SECKEL SYNDROME 2; SCKL2	0.10702264	2.5024298533446894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.106306421	2.4856830434441606
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.10534457600000001	2.463192945626631
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.10487819999999999	2.4522880265806837
LISSENCEPHALY, X-LINKED, 1; LISX1	0.10470639600000001	2.4482708629363934
MEIER-GORLIN SYNDROME 5; MGORS5	0.10463121	2.4465128452781335
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.104199582	2.4364204125672653
MACHADO-JOSEPH DISEASE; MJD	0.10371747	2.425147550475135
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.10261615800000001	2.3993964007497435
COFFIN-SIRIS SYNDROME 2; CSS2	0.10260422800000002	2.3991174505374295
SECKEL SYNDROME 5; SCKL5	0.102120105	2.387797566745637
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.10176034600000002	2.379385592778172
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.10160813500000002	2.3758265575085558
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.10129318999999999	2.368462435579198
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.101258653	2.367654882898336
CHROMOSOME 19p13.13 DELETION SYNDROME	0.101056863	2.3629365791814174
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.10102548	2.362202774109075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.100899502	2.359257125337332
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.10084459500000001	2.3579732762755117
Bangstad syndrome	0.10084459500000001	2.3579732762755117
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.10084459500000001	2.3579732762755117
WOODHOUSE-SAKATI SYNDROME	0.10084459500000001	2.3579732762755117
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.10084459500000001	2.3579732762755117
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.10084459500000001	2.3579732762755117
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.10084459500000001	2.3579732762755117
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.10084388200000001	2.3579566047330656
CHROMOSOME 4q21 DELETION SYNDROME	0.10084388200000001	2.3579566047330656
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.10027736100000001	2.344710070514262
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.100206751	2.3430590500204236
LISSENCEPHALY, X-LINKED, 2	0.10014024099999999	2.341503896741211
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.1	2.338224746973808
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.1	2.338224746973808
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.1	2.338224746973808
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	2.338224746973808
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.1	2.338224746973808
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	2.338224746973808
#275200 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1;;THYROTROPIN RESISTANCE;;THYROID-STIMULATING HORMONE, RESISTANCE TO; RTSH;;TSH RESISTANCE;;HYPOTHYROIDISM, NONAUTOIMMUNE;;HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE;;HYPOTHYROIDISM DUE TO UNRESPONSIVENESS TO THYROTROPIN	0.1	2.338224746973808
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.1	2.338224746973808
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.1	2.338224746973808
DYSTONIA, JUVENILE-ONSET	0.1	2.338224746973808
THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	0.1	2.338224746973808
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.1	2.338224746973808
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1	2.338224746973808
HYPOPHOSPHATASIA, INFANTILE	0.099791131	2.333340920327051
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.099776318	2.332994559095282
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.09970748299999999	2.331385042090702
BARAITSER-WINTER SYNDROME 2; BRWS2	0.09960343600000002	2.328952189388219
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.09926045800000001	2.320932592915543
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.098923591	2.3130558853571546
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.09884598	2.311241165748781
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.09878778999999999	2.3098805527685164
MIRAGE SYNDROME; MIRAGE	0.09870509300000001	2.3079469110495117
PHENYLKETONURIA	0.097624556	2.282681527515303
MAPLE SYRUP URINE DISEASE; MSUD	0.09704092600000001	2.2690349464245405
Trichothiodystrophy 5, nonphotosensitive	0.09686233000000001	2.264858970555435
CIRCUMVALLATE PLACENTA SYNDROME	0.0965309	2.2571093922765395
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.09651361000000001	2.256705113217788
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.09646466000000001	2.255560552204144
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.09609137200000001	2.2468322398106606
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.09554232100000001	2.2339941934551537
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.09554232100000001	2.2339941934551537
#613612 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I;;CDG IIi; CDGIIi	0.09547116500000001	2.2323304062541967
LISSENCEPHALY 4	0.09518962300000001	2.225747321537072
OROFACIODIGITAL SYNDROME IV; OFD4	0.09512851	2.224318362247453
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.095110522	2.223897762379968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.09509800000000002	2.223604969877152
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.09462657000000001	2.212581876952493
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.09440113	2.2073105830829154
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.09387440800000002	2.1949946389311603
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.09376451200000002	2.192425023463226
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.093425022	2.184486984269724
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.093029205	2.175231893222995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.09284626100000001	2.170954251341892
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.092803	2.1699427119341026
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.09258949200000001	2.1649504150413343
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.09254475100000001	2.163904269907291
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.09252586200000001	2.163462602634835
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.09211477500000001	2.1538504646692425
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.09153002000000002	2.140177578550076
EVEN-PLUS SYNDROME	0.09121943200000002	2.132915333072945
MECKEL SYNDROME, TYPE 10; MKS10	0.091193551	2.1323101771261803
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.09111782500000001	2.130539533054287
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.0909091	2.1256590734511662
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.09037555000000001	2.1131834753136873
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.09032561199999999	2.112015812639543
MUCOLIPIDOSIS IV; ML4	0.09001475700000001	2.1047473241023384
Adrenoleukodystrophy	0.089202751	2.0857607988634257
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.08880910500000001	2.076556470675954
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.08873971800000002	2.074934046670771
CHIARI MALFORMATION TYPE II	0.08848521000000001	2.0689830776317426
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.08840215100000001	2.067040971539154
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.08834731000000001	2.065758665705666
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.088098447	2.059939689453604
MEESTER-LOEYS SYNDROME; MRLS	0.08802814000000002	2.05829575378075
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.08782067099999999	2.05344466228045
MEGALENCEPHALY WITH DYSMYELINATION	0.087721351	2.0511223374617558
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.08712878300000002	2.0372667658431083
ARGININOSUCCINIC ACIDURIA	0.08677370800000002	2.028964314322791
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.08674138199999999	2.0282084597910837
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.08666601	2.026446093034795
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.085721915	2.0043710301098523
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.08530353099999999	1.9945882718844736
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.08523433	1.9929701969773204
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.08511982000000001	1.990292695819561
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.085042751	1.9884906493893153
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.08503404	1.9882869666316065
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.08487732	1.9846225008081493
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.08487732	1.9846225008081493
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.084632422	1.9788962351673052
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.08417718200000002	1.9682517008291822
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.08412700000000001	1.9670783328866557
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.08333330000000001	1.9485198430699247
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.08333330000000001	1.9485198430699247
DEMENTIA, LEWY BODY; DLB	0.08333330000000001	1.9485198430699247
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.08333330000000001	1.9485198430699247
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.08333330000000001	1.9485198430699247
#604286 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E	0.08333330000000001	1.9485198430699247
PARKINSON DISEASE 21; PARK21	0.08333330000000001	1.9485198430699247
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.08333330000000001	1.9485198430699247
#614251 PARKINSON DISEASE 18; PARK18	0.08333330000000001	1.9485198430699247
POLYCYSTIC KIDNEY DISEASE 3	0.08333330000000001	1.9485198430699247
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.08333330000000001	1.9485198430699247
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.08326286800000002	1.9468729846161361
WILLIAMS-BEUREN SYNDROME; WBS	0.082782125	1.935632132820791
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.082574682	1.9307816492589263
EPISODIC ATAXIA, TYPE 2	0.08247866000000001	1.9285364390923876
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.08222293100000001	1.9225569203291988
SPINOCEREBELLAR ATAXIA 47; SCA47	0.08203914600000001	1.9182596139779728
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.08187159999999999	1.9143420119434078
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.08173079999999999	1.9110497914996687
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.08170901000000001	1.9105402923273034
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.08169727500000001	1.9102659016532464
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.08162877099999999	1.9086641241725786
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.081155518	1.897598405410783
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.081100277	1.896306746678307
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.08107479000000001	1.8957108033370462
ADENYLOSUCCINASE DEFICIENCY	0.08104741800000001	1.8950707844593047
MOEBIUS SYNDROME; MBS	0.0810471	1.895063348904609
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.08044414800000002	1.8809649760282359
ACROCALLOSAL SYNDROME; ACLS	0.08023119600000002	1.8759856796650602
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.08022053	1.8757362846135477
MENKES DISEASE	0.07995895600000001	1.8696200966138985
MEVALONIC ACIDURIA; MEVA	0.079802652	1.8659653578053885
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.079771303	1.8652323477294595
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.079470382	1.8581961384386187
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.07927307	1.8535825404258695
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.079004882	1.8473117022414554
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.078896211	1.8447707300266716
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.07885049999999999	1.843701904112582
GLUTARIC ACIDEMIA I; GA1	0.078693551	1.8400320837544546
#614970 JOUBERT SYNDROME 20; JBTS20	0.078621682	1.8383516250110519
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.078506832	1.8356661738891524
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.078125	1.8267380835732876
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.07783885100000001	1.8200472768420697
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.07776698200000001	1.818366818098667
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.07766640999999999	1.81601521870614
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.07720239100000001	1.80516541161748
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.077132222	1.8035247026947758
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07700563	1.8005646972230869
#227500 FACTOR VII DEFICIENCY;;F7 DEFICIENCY;;HYPOPROCONVERTINEMIA	0.07692310000000001	1.7986349603394094
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.07692310000000001	1.7986349603394094
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.07692310000000001	1.7986349603394094
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.07692310000000001	1.7986349603394094
Glanzmann thrombasthenia	0.07692310000000001	1.7986349603394094
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0769171	1.7984946668545907
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.07691471	1.798438783283138
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.07649260500000002	1.7885690197149247
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.07642184199999999	1.786914421737223
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.076301435	1.7840990354661346
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.07629209500000002	1.7838806452747675
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.076144343	1.7804258714466183
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.075455403	1.764316905874817
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.07518308000000001	1.7579493820971157
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.07499547299999999	1.7535627087960601
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.07478430000000001	1.7486250094511337
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.074624701	1.7448932261372108
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.07445285800000001	1.7408751505852686
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.073889261	1.7276969860580667
CORNELIA DE LANGE SYNDROME 1	0.073755456	1.7245683244353782
JOUBERT SYNDROME 32; JBTS32	0.07370028199999999	1.7232782323134828
TONNE-KALSCHEUER SYNDROME; TOKAS	0.073683587	1.7228878656919755
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.07331523999999999	1.7142750849832398
PRIMROSE SYNDROME; PRIMS	0.073193325	1.7114244382829669
BRANCHIOOCULOFACIAL SYNDROME	0.073165841	1.7107818005935087
TANGIER DISEASE; TGD	0.0731092	1.7094574067145751
IMMUNODEFICIENCY 9; IMD9	0.0730328	1.7076710030078872
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.072662268	1.6990071320884301
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.07265855	1.6989201968923378
PSEUDOTRISOMY 13 SYNDROME	0.07244095	1.6938322198429228
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.072225613	1.6887971568195315
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.071991708	1.6833279322251224
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.071991708	1.6833279322251224
ERYTHERMALGIA, PRIMARY	0.0714995	1.6718190029625375
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.07142860000000001	1.6701612016169334
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.07142860000000001	1.6701612016169334
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.071333516	1.6679379239985206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.071232486	1.665575615536653
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.07114891300000001	1.6636214909688647
CHIARI MALFORMATION TYPE I	0.0708748	1.6572121129681923
SYRINGOMYELIA, ISOLATED	0.0708748	1.6572121129681923
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.070818698	1.6559003221206452
POPOV-CHANG SYNDROME; POPCHAS	0.070640942	1.6517439873394144
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0704887	1.6481842272201266
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.07037592000000001	1.6455471773504895
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.070135733	1.6399310654774755
METACHROMATIC LEUKODYSTROPHY	0.07004734600000001	1.637864378770368
OCULODENTODIGITAL DYSPLASIA; ODDD	0.07000015600000001	1.6367609705122708
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.06978472999999999	1.6317238264688547
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.069420203	1.6232003659454537
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.06913029999999999	1.6164217822572342
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.068797037	1.608629344318727
MYOTONIC DYSTROPHY 1	0.06859847	1.6039864015854035
COFFIN-SIRIS SYNDROME 1; CSS1	0.068543468	1.602700331210073
CROME SYNDROME	0.068427046	1.599978123195151
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.068408943	1.5995548343692063
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.068336862	1.5978694185893403
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.068316461	1.59739239735871
ALZHEIMER DISEASE 3; AD	0.068236051	1.5955122308396685
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.068189272	1.5944184326852815
THORACOABDOMINAL SYNDROME	0.06805556	1.591291945611608
PEROXISOME BIOGENESIS DISORDER 11B	0.06805556	1.591291945611608
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.06805556	1.591291945611608
MECKEL SYNDROME, TYPE 6; MKS6	0.06805556	1.591291945611608
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.06786833	1.5869140874178491
LYMPHEDEMA, HEREDITARY, III	0.067510582	1.578549135150045
FOCAL DERMAL HYPOPLASIA; FDH	0.067349515	1.5747830266968368
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.067299618	1.5736163226948394
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.06702022	1.5670833695162893
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.06702022	1.5670833695162893
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.06702022	1.5670833695162893
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I	0.06702022	1.5670833695162893
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.0666667	1.5588172773907873
Lymphatic malformation 1	0.0666667	1.5588172773907873
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.0666667	1.5588172773907873
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.0666667	1.5588172773907873
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.0666667	1.5588172773907873
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0666667	1.5588172773907873
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0666667	1.5588172773907873
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0666667	1.5588172773907873
#613480 LYMPHEDEMA, HEREDITARY, IC;;LMPH1C	0.0666667	1.5588172773907873
#614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;APLAID	0.0666667	1.5588172773907873
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.0666667	1.5588172773907873
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.0666667	1.5588172773907873
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.066465777	1.5541192460824254
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.066420708	1.5530654315712116
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.06612594000000001	1.5461730932490523
HEMIFACIAL MICROSOMIA	0.06607400499999999	1.544958736226711
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.065629682	1.5345694658842146
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.065544548	1.5325788416281259
CHROMOSOME 18Q DELETION SYNDROME	0.06532492599999999	1.527443585674327
MEIER-GORLIN SYNDROME 7	0.06512958199999999	1.5228760039245983
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.06512288	1.5227192961020564
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.06512288	1.5227192961020564
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.065104228	1.522283170422251
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.064620105	1.5109632866304588
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.06459931	1.5104770527943254
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.064527122	1.5087891351139804
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.064098528	1.4987676441419355
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.064087882	1.4985187167353726
RETT SYNDROME, CONGENITAL VARIANT	0.063956881	1.4954556189345891
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.06390428000000001	1.494225689335434
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.063880793	1.493676510489112
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.063734207	1.490249000361513
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.063734207	1.490249000361513
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.06359453799999999	1.486983225239662
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.06343372800000001	1.4832231260240536
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.06328301	1.4796990004499095
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.063260913	1.4791823229275707
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.063036911	1.4739446527298545
JOUBERT SYNDROME 13; JBTS13	0.06263360000000001	1.4645143351205872
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.0625	1.46139046685863
HYPOGONADISM-CATARACT SYNDROME	0.0625	1.46139046685863
ANENCEPHALY; ANPH	0.0625	1.46139046685863
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.0625	1.46139046685863
MECKEL SYNDROME, TYPE 5	0.0625	1.46139046685863
PREMATURE OVARIAN FAILURE 11	0.0625	1.46139046685863
46,XY SEX REVERSAL 5	0.0625	1.46139046685863
301410 NEURAL TUBE DEFECTS, X-LINKEDSPINA BIFIDA, X-LINKED, INCLUDED	0.0625	1.46139046685863
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.062279603	1.456237089663042
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.062268790000000004	1.455984257421152
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.062121496	1.4525401926623442
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.06212116	1.4525323362271942
MEGALENCEPHALY	0.061955755	1.4486647955844625
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.061802305999999994	1.4450768130924783
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.061744058000000004	1.4437148439418612
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.06154940999999999	1.4391635362363713
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.061474278	1.437406781219475
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0611979	1.430944442428284
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.060601656	1.4170029176679373
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.060400391000000005	1.4122968896309407
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.0602928	1.4097811702434242
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0602928	1.4097811702434242
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.060183187	1.4072181719515235
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.060175151999999996	1.4070302955931042
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0601604	1.4066853606784306
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.060078106000000006	1.4047611420051562
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.060036633	1.4037914100558435
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.059946793	1.4016907489431623
LUSCAN-LUMISH SYNDROME; LLS	0.05993066799999999	1.4013137102027127
LATHOSTEROLOSIS	0.059886866	1.4002895209990434
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.059858705	1.3996310535280478
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.059667382	1.3951574917953953
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.059530188	1.391949587736032
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.05950448	1.3913484769180802
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.059297804999999995	1.3865159509222718
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.059031755	1.380295103982948
LOEYS-DIETZ SYNDROME 5	0.0589113	1.377478595363981
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0588235	1.375425634036138
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0588235	1.375425634036138
#611722 KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY;;SAPOSIN A DEFICIENCY	0.0588235	1.375425634036138
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.058708433000000004	1.3727351089665376
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.058516910000000005	1.368256870784391
MYOPATHY, DISTAL, 1; MPD1	0.05845321	1.3667674216205685
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.058337257	1.36405617987971
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.058325510000000004	1.363781508618683
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.05818716	1.3605465746812448
SIFRIM-HITZ-WEISS SYNDROME	0.058171034999999996	1.3601695359407953
NIEMANN-PICK DISEASE, TYPE C2	0.058159828000000004	1.359907491093402
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.058159828000000004	1.359907491093402
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.057988740000000004	1.3559070691382993
PEHO-LIKE SYNDROME; PEHOL	0.05795262200000001	1.3550625491241874
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.057746861000000003	1.3502513945025667
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057674992	1.348570935759164
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057674992	1.348570935759164
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.057674992	1.348570935759164
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.057464533000000005	1.3436499313389303
SMITH-MAGENIS SYNDROME; SMS	0.057299067999999995	1.33978098776135
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.056969988	1.3320863577640087
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.056922032	1.33096503870435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.056900382	1.33045881304663
Miller-Dieker syndrome (MDS)	0.056831110000000004	1.3288390779999064
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.056707268	1.325943373708759
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.05668692499999999	1.325467708648482
Pierpont syndrome	0.056511337999999994	1.3213620899620133
MICROPHTHALMIA, SYNDROMIC 1	0.056391556	1.3185613175955933
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.056357781999999995	1.31777160556955
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.056093580000000004	1.3115939690235505
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.055879651	1.306591828204597
MAST SYNDROME	0.0556138	1.3003756343325195
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.055570063	1.2993529649749358
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.055555600000000004	1.2990147875297808
ALZHEIMER DISEASE 4	0.055555600000000004	1.2990147875297808
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.055555600000000004	1.2990147875297808
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.055555600000000004	1.2990147875297808
Early-onset Alzheimer disease with cerebral amyloid angiopathy	0.055555600000000004	1.2990147875297808
ALZHEIMER DISEASE	0.055555600000000004	1.2990147875297808
PHEOCHROMOCYTOMA	0.055555600000000004	1.2990147875297808
DEMENTIA, FAMILIAL DANISH	0.055555600000000004	1.2990147875297808
ALZHEIMER DISEASE 2	0.055555600000000004	1.2990147875297808
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.055555600000000004	1.2990147875297808
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.055555600000000004	1.2990147875297808
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.05531843299999999	1.2934692900441251
#613205 MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED;;MDCL	0.05484459999999999	1.2823900095787968
#613723 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q	0.0547729	1.2807135024352168
YOU-HOOVER-FONG SYNDROME; YHFS	0.054750992	1.2802012441576498
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0546932	1.2788499373118787
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.05466125	1.2781028745052205
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	1.2744681041360497
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.054474550999999996	1.2737374322848678
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.05436576	1.2711936542003877
HYDROXYKYNURENINURIA	0.054320076999999994	1.2701254829892275
PEHO SYNDROME; PEHO	0.054173532999999996	1.2666989549160224
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.05390711	1.2604693863983922
GOLDBERG-SHPRINTZEN SYNDROME	0.053861617	1.2594056578142514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.053646952	1.25438630766116
AYME-GRIPP SYNDROME; AYGRP	0.053598756	1.2532593768621085
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.05354003	1.2518862309972008
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.053509177	1.251164818516017
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.053476195	1.25039362522997
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.053476195	1.25039362522997
NETHERTON SYNDROME; NETH	0.053475482	1.2503769536875242
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0533869	1.2483057074421597
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.053363152	1.2477504258292482
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.053280778	1.2458243365761763
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.053191108	1.2437276504455648
MENTAL RETARDATION, BUENOS AIRES TYPE	0.053130165	1.2423026661380165
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.053102695	1.241660355800023
N-ACETYLASPARTATE DEFICIENCY; NACED	0.053035143	1.2400808382189472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.05302709	1.2398925409800734
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.053026721	1.239883912930757
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.052700880000000005	1.2322650180329702
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	1.2306450959282667
THROMBOCYTOPENIA 1	0.0526316	1.2306450959282667
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0526316	1.2306450959282667
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0526316	1.2306450959282667
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0526316	1.2306450959282667
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	1.2306450959282667
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	1.2306450959282667
ROWLEY-ROSENBERG SYNDROME	0.0526316	1.2306450959282667
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.05223923999999999	1.22147083731104
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.052191261	1.2203489804596896
CEREBELLOFACIODENTAL SYNDROME	0.052189417	1.2203058635953554
CRI-DU-CHAT SYNDROME	0.052120105	1.2186851932587328
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.05209558	1.2181117436395377
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.052066463	1.2174309227399613
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.05205162199999999	1.2170839068052628
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0518659	1.2127413090406882
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.05161133999999999	1.2067891241247914
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.05132043299999999	1.1999870646601125
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.05101006	1.1927298463661875
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.05101006	1.1927298463661875
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.05101006	1.1927298463661875
MCLEOD SYNDROME; MCLDS	0.05101006	1.1927298463661875
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.05101006	1.1927298463661875
LATERAL MENINGOCELE SYNDROME	0.0509747	1.1919030500956576
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.050887892	1.1898732839573045
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.050844595	1.1888609027886072
Smith-Magenis Syndrome	0.050844595	1.1888609027886072
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.050843882	1.1888442312461616
BAKER-GORDON SYNDROME; BAGOS	0.050799682	1.187810735907999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.050462056000000005	1.1799162812237813
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.050323951	1.176687075936973
#137580 GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDERCHRONIC MOTOR TICS, INCLUDED	0.05	1.169112373486904
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.049945632999999996	1.1678411508387165
LESCH-NYHAN SYNDROME; LNS	0.04990817499999999	1.166965298612995
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.04980756	1.1646126937838275
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.04978772799999999	1.1641489770520075
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.049775713	1.1638680393486587
JOUBERT SYNDROME 30; JBTS30	0.049724498	1.1626705175444962
PAPILLORENAL SYNDROME	0.049379346	1.154600088065821
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.04930962	1.1529697374787462
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.04930962	1.1529697374787462
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.04930962	1.1529697374787462
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.04930962	1.1529697374787462
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.04930962	1.1529697374787462
#118210 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA1;;HMSN IIA1;;HMSN2A1	0.04930962	1.1529697374787462
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.049307476999999995	1.1529196293224182
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.04922543	1.151001186064269
HOLOPROSENCEPHALY 11	0.049161642000000005	1.1495096792626693
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.04914993000000001	1.1492358263803037
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.048954105000000005	1.1446569977695422
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.04882216300000001	1.1415718972738902
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.0488017	1.141093426343917
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.0488017	1.141093426343917
WARBURG MICRO SYNDROME 3; WARBM3	0.048705421	1.138842206939778
HOLOPROSENCEPHALY 5; HPE5	0.048519547	1.1344960550735879
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.048446528	1.132788706745595
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.04831776	1.1297778215034118
BOHRING-OPITZ SYNDROME	0.048154523000000005	1.1259609735731944
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.048058728	1.1237210711768306
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.04801736799999999	1.122753981421482
JOUBERT SYNDROME 17; JBTS17	0.047852482	1.118898576165187
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.047737861	1.1162184795779582
JACOBSEN SYNDROME	0.047675665	1.1147641973143303
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.047619	1.1134392422614576
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.047619	1.1134392422614576
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.047587307	1.1126981886923992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.047427791000000004	1.1089683461050164
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.04738091	1.1078721629613877
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.04737276	1.1076815976445091
AGNATHIA-OTOCEPHALY COMPLEX	0.04704225	1.0999535310332862
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.047021007	1.0994568219502863
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.046997334999999994	1.0989033173881828
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.046859403	1.095678157230187
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.04673001	1.0926526580833351
MEIER-GORLIN SYNDROME 6; MGORS6	0.046526704999999995	1.0878989302614999
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.04651989	1.0877395802449938
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.046298382	1.0825602253724669
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.046246715	1.081352134792448
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.045944364999999994	1.0742825122699726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.045810483	1.071152050214229
RAYNAUD-CLAES SYNDROME; MRXSRC	0.045782433	1.0704961781727032
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.04577669300000001	1.070361964072227
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.04549938	1.0638777628796514
GLYCOGEN STORAGE DISEASE XI; GSD11	0.0454545	1.0628283676132095
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0454545	1.0628283676132095
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.0454545	1.0628283676132095
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.045426258	1.062168006180169
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.04542591	1.0621598691580498
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.045423633	1.062106627780561
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.045285138	1.0588683034172397
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0450886	1.0542728032640325
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.04481313699999999	1.0478318592292757
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.044616891	1.0432431866923295
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.044496522	1.0404286889466448
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.044491556999999994	1.0403125960879573
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.044117699999999996	1.0315709791956635
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.044117699999999996	1.0315709791956635
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.04407793	1.0306410672137922
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0440228	1.0293520039107855
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.043937305	1.0273529386633604
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.043879737999999995	1.0260068928232697
AICARDI-GOUTIERES SYNDROME 7	0.043813448	1.0244568836385008
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0437524	1.0230294441949683
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.043488813	1.0168661877311624
KEARNS-SAYRE SYNDROME; KSS	0.043461121000000005	1.0162186865342306
#614465 JOUBERT SYNDROME 16; JBTS16	0.043402800000000005	1.014855010479548
Polyarteritis nodosa, childhood-onset	0.0432773	1.0119205384220957
BRUNNER SYNDROME; BRNRS	0.042661795	0.9975286481932346
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.04265423000000001	0.9973517614911263
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.04264189499999999	0.9970633414685867
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.04259256	0.9959097782896673
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.042497367999999994	0.9936839753885278
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.042398487	0.9913719153764728
KLEEFSTRA SYNDROME 2; KLEFS2	0.042341238	0.9900333050910778
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.042185611000000005	0.986394396064105
COMBINED SAPOSIN DEFICIENCY	0.04204573	0.9831236639057905
#614302 EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7	0.04178191	0.976954959378324
#612998 EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 4 WITH VARIABLE FEATURES	0.04178191	0.976954959378324
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.041676413	0.9744882024170093
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.041649738	0.9738644809657538
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.04161721299999999	0.9731039733668005
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.041614573	0.9730422442334806
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.041484213	0.9699941344533255
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.04127551	0.9651141892596489
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.041209220000000005	0.9635641800748799
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.0411129	0.9613120019985946
CHROMOSOME 2q37 DELETION SYNDROME	0.041065728	0.9602090146209522
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.040979172	0.9581851408089614
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.04097633	0.9581186884616524
REVESZ SYNDROME	0.04097564199999999	0.9581026014753932
FONTAINE PROGEROID SYNDROME; FPS	0.04094879	0.9574747413663358
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.040882242	0.9559186995617197
#300706 MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST;;MENTAL RETARDATION AND MACROCEPHALY SYNDROME	0.040844595	0.9550384280912264
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.040821602	0.9545008000751549
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.04073268	0.9524216038656509
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.04073268	0.9524216038656509
Ullrich congenital muscular dystrophy 1	0.040584890000000005	0.9489659415120983
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0405229	0.9475164759914492
MEHMO SYNDROME; MEHMO	0.040511307999999996	0.94724542897878
184705 STEINFELD SYNDROME	0.04	0.9352898987895231
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.04	0.9352898987895231
MICROTIA-ANOTIA	0.04	0.9352898987895231
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.039826663	0.9312368901598611
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.03964672599999999	0.9270295586968987
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.039538039999999997	0.9244882357484028
OROFACIODIGITAL SYNDROME XV; OFD15	0.039514890000000004	0.9239469367194785
COFFIN-SIRIS SYNDROME 8; CSS8	0.039377251	0.9207286275599913
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.039306095	0.9190648403590345
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.039305382	0.9190481688165886
RITSCHER-SCHINZEL SYNDROME 1	0.039265842	0.9181236347516352
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.039256335999999996	0.9179013631071877
GALACTOSE EPIMERASE DEFICIENCY	0.039237856999999994	0.9174692825561943
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.03917764	0.9160612737603093
SALIH MYOPATHY; SALMY	0.03885728	0.9085705369609041
STROMME SYNDROME; STROMS	0.038851250000000004	0.9084295420086616
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.038737970000000004	0.9057808010152897
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.03861353000000001	0.9028711141401555
THUMBS, CONGENITAL CLASPED	0.0384757	0.8996483389714014
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.038470103	0.8995174685323132
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.038465131	0.8994012119978937
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0384615	0.8993163110573311
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.038357007	0.8968730298724757
FOLATE MALABSORPTION, HEREDITARY	0.038318528	0.8959733043720877
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.038237855999999994	0.8940870117042088
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.038237142999999994	0.8940703401617629
RAINE SYNDROME	0.037977951999999995	0.8880098720578341
SNEDDON SYNDROME	0.037961731	0.8876305886216275
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.037884100000000004	0.8858154013683044
GABRIELE-DE VRIES SYNDROME; GADEVS	0.03763331699999999	0.8799515312011008
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.037492733	0.8766643613228153
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.037345185999999995	0.8732143808553978
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.037287823000000005	0.8718731049937913
AMYLOIDOSIS, FINNISH TYPE	0.037037	0.8660082995366892
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.036989810000000005	0.8649048912785925
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.03695133	0.8640051423959566
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.036921276999999995	0.8633024357127487
JOUBERT SYNDROME 31; JBTS31	0.036900752	0.8628225150834324
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.036838876	0.8613757151389949
#607641 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B;;HMN VIIB;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB;;DHMN7B;;NEUROPATHY, DISTAL HEREDITARY MOTOR, WITH VOCAL CORD PARALYSIS, TYPEVIIB;;LOWER MOTOR NEURON DISEASE, DYNACTIN TYPE	0.0366713	0.857457411637006
CAROLI DISEASE, ISOLATED	0.03665818	0.857150636550203
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.03665818	0.857150636550203
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.03665818	0.857150636550203
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.036630051000000004	0.8564929173111269
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.036630051000000004	0.8564929173111269
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.036630051000000004	0.8564929173111269
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.036630051000000004	0.8564929173111269
OROFACIODIGITAL SYNDROME IX; OFD9	0.036602192	0.8558415112788672
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.036558895	0.85482913011017
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.036558895	0.85482913011017
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.03655081	0.8546400846393774
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.036251595	0.8476437654627195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.036242433000000004	0.8474295373114018
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.036208443	0.8466347747199056
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.036206818	0.8465967785677672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.03613783799999999	0.8449838711373043
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.03597557	0.8411896806048851
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.035942668	0.8404203578986358
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.03594262	0.8404192355507573
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.035915832999999994	0.8397928952877852
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.035811352	0.8373498946898996
PEROXISOME BIOGENESIS DISORDER 6B	0.035811352	0.8373498946898996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.03575831	0.83610965351961
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.035742113	0.8357309312573424
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.035714300000000004	0.8350806008084667
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.035714300000000004	0.8350806008084667
#615361 HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2	0.035714300000000004	0.8350806008084667
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.035626118	0.8330187074620903
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.03550158	0.8301067291267039
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.03548217	0.8296528797033165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.035377483	0.827205062362452
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.035377133	0.8271968785758375
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03533163	0.826132916169222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.035326682	0.8260172208087416
BARAITSER-WINTER SYNDROME 1; BRWS1	0.035323458	0.8259418364428993
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.035321813	0.8259033726458117
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.035260252000000006	0.8244639381093272
MECKEL SYNDROME 13; MKS13	0.035213407	0.8233685967266072
JOUBERT SYNDROME 24	0.035036512000000006	0.8192323940604479
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.035026917000000005	0.8190080413959757
MYELOCEREBELLAR DISORDER	0.03496747	0.8176180369306422
MENTAL RETARDATION, X-LINKED 90	0.03486232799999999	0.8151595806671788
LANDAU-KLEFFNER SYNDROME	0.03486232799999999	0.8151595806671788
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.03480822	0.8138944140210864
NEUROPATHY, PAINFUL	0.0347059	0.8115019424599826
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.034572562	0.8083842003468629
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.034532485999999994	0.8074471333972655
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.034414948	0.8046988307941675
JOUBERT SYNDROME 25	0.034368812	0.8036200674249037
LETTERER-SIWE DISEASE	0.0343137	0.8023314250023516
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.034285143000000004	0.8016636981613583
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.034232986	0.800444150280079
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.034213986999999994	0.7999999109604015
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.034207962	0.7998590329193964
2q33.1 deletion syndrome	0.034018445999999994	0.7954277229079213
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.034017732999999994	0.7954110513654754
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.03394657699999999	0.7937472641645186
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.033886893	0.792351718106535
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.033787053	0.7900172345191563
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.033775263	0.7897415578214881
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.033760243	0.7893903564644927
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.033662133	0.7870963241652367
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.033547445999999995	0.7844146843496747
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.033370105	0.7802680532011439
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.033369392	0.780251381658698
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.03333885599999999	0.779537381349962
INFANTILE LIVER FAILURE SYNDROME 1	0.033338142999999994	0.7795207098075161
OROFACIODIGITAL SYNDROME XVI; OFD16	0.033316522	0.779015162234973
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.033205682	0.7764234739254272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.033186761	0.7759810584210524
GRISCELLI SYNDROME, TYPE 2; GS2	0.033173851	0.775679193606218
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.033173851	0.775679193606218
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.033173851	0.775679193606218
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.033173851	0.775679193606218
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0331536	0.7752056797127084
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.033102694999999994	0.7740154064052612
MENTAL RETARDATION, X-LINKED 105; MRX105	0.033102694999999994	0.7740154064052612
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.033102694999999994	0.7740154064052612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.033102694999999994	0.7740154064052612
HISTIDINEMIA	0.033102694999999994	0.7740154064052612
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.033101981999999995	0.7739987348628152
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.033010345999999996	0.7718560792336784
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.032935173	0.7700983655446358
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.03286478	0.7684524189984987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.032733563	0.765384270632262
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.032446943	0.7586824508624856
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.032435982	0.7584261580479699
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.032422391999999994	0.758108393304856
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.032422391999999994	0.758108393304856
AICARDI-GOUTIERES SYNDROME 6	0.032422391999999994	0.758108393304856
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.032365705	0.7567829238425391
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.032325238000000006	0.7558367144341813
GM2-GANGLIOSIDOSIS, AB VARIANT	0.032294843000000004	0.7551260110223386
BREATH-HOLDING SPELLS	0.0322581	0.7542668771035579
CREUTZFELDT-JAKOB DISEASE; CJD	0.0322581	0.7542668771035579
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0322581	0.7542668771035579
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.0322581	0.7542668771035579
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.0322581	0.7542668771035579
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.0322581	0.7542668771035579
602197 CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3;;CDR3	0.0322581	0.7542668771035579
#614321 MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT	0.0322581	0.7542668771035579
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.03216706	0.7521381572939129
MENTAL RETARDATION, X-LINKED 9	0.03206263299999999	0.7496964193373905
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.032016027999999995	0.7486066896940633
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.0319473	0.7469996745899632
INFANTILE SIALIC ACID STORAGE DISEASE	0.031942803	0.7468945246230919
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.031902608	0.7459546751860457
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.03182861	0.7442244356377801
ANGELMAN SYNDROME	0.031805433	0.743682505288174
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.03178701	0.7432517341430389
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.031692407	0.7410397033856594
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.031674792	0.7406278250964798
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.031626310000000005	0.7394942069746522
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.031625638	0.7394784941043523
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.031580492	0.7384228791600836
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.031574351	0.738279288778372
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.03152111	0.7370343945408356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.031513603	0.7368588640090804
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.031246833	0.7306211818515783
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.031218750999999996	0.729964561578133
KEUTEL SYNDROME; KTLS	0.031218750999999996	0.729964561578133
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.031185118	0.7291781464489835
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.031171433	0.72885816039236
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.031147594999999997	0.7283007743771763
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.031146881999999997	0.7282841028347304
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.031146881999999997	0.7282841028347304
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.031069503	0.7264748079077696
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.03100932	0.7250675941082984
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.03073168	0.7185757469208003
SECKEL SYNDROME 9; SCKL9	0.030623732	0.7160516800709371
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.030331033	0.7092077196187921
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.030325795	0.7090852434065457
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.030302999999999997	0.7085522450754729
TERATOMA, PINEAL	0.030302999999999997	0.7085522450754729
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.030302999999999997	0.7085522450754729
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.030302999999999997	0.7085522450754729
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.030302999999999997	0.7085522450754729
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.030302999999999997	0.7085522450754729
241519 HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS	0.030302999999999997	0.7085522450754729
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.030302999999999997	0.7085522450754729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.030214170999999998	0.7064752234149836
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.03019573	0.7060440313893942
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.030079937999999997	0.7033365541903782
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.029947443	0.7002385233118753
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.029945760000000002	0.7001991709893838
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.029849477	0.6979478580562549
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.029807217	0.6969597242781839
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.029727111	0.695086665962373
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0296715	0.6937863557983334
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.029550809999999997	0.6909643523512106
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.029537433000000002	0.690651568026808
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.029487151	0.6894758618595347
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.02948523	0.6894309445621454
JOUBERT SYNDROME 15	0.029466277000000003	0.6889877808258514
JOUBERT SYNDROME 27	0.029466277000000003	0.6889877808258514
JOUBERT SYNDROME 8	0.029466277000000003	0.6889877808258514
MENTAL RETARDATION, X-LINKED 104; MRX104	0.029447458	0.6885477503107182
Yao syndrome	0.0294118	0.6877139861304423
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.0294118	0.6877139861304423
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	0.6877139861304423
IMMUNODEFICIENCY 10; IMD10	0.0294118	0.6877139861304423
MAJEED SYNDROME	0.0294118	0.6877139861304423
STUVE-WIEDEMANN SYNDROME	0.0294118	0.6877139861304423
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0294118	0.6877139861304423
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	0.6877139861304423
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0294118	0.6877139861304423
DOHLE BODIES AND LEUKEMIA	0.0294118	0.6877139861304423
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	0.6877139861304423
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	0.6877139861304423
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0294118	0.6877139861304423
IMMUNODEFICIENCY 61; IMD61	0.0294118	0.6877139861304423
MARSILI SYNDROME; MARSIS	0.0294118	0.6877139861304423
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0294118	0.6877139861304423
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0294118	0.6877139861304423
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.02940952	0.6876606746062114
KAPUR-TORIELLO SYNDROME	0.029361251	0.6865320369030947
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.029320051999999996	0.6855687116895888
TEMPLE SYNDROME	0.02931946	0.6855548693990867
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.029289382000000003	0.6848515781596921
CEREBROOCULONASAL SYNDROME	0.029215185	0.6831166855441798
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.029214829999999997	0.6831083848463281
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.029196382	0.6826770291450064
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.029031291	0.6788168305279798
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.0289916	0.6778887657436584
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0289916	0.6778887657436584
COFFIN-SIRIS SYNDROME 5	0.028836098	0.6742527794976193
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.028754887	0.6723538837983544
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.02875461	0.6723474069158053
#300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	0.02875461	0.6723474069158053
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.028690124999999997	0.670839602687719
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.028661651	0.6701738165732659
#614815 JOUBERT SYNDROME 18; JBTS18	0.028622395000000002	0.6692559230665939
JOUBERT SYNDROME 33; JBTS33	0.028621682000000002	0.669239251524148
#615665 JOUBERT SYNDROME 22; JBTS22	0.028621682000000002	0.669239251524148
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.0285714	0.6680635453568746
SICKLE CELL ANEMIA	0.0285714	0.6680635453568746
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	0.6680635453568746
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0285714	0.6680635453568746
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	0.6680635453568746
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0285714	0.6680635453568746
CARDIOMYOPATHY, DILATED, 1E	0.0285714	0.6680635453568746
DERMOGRAPHISM, FAMILIAL	0.0285714	0.6680635453568746
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	0.6680635453568746
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	0.6680635453568746
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0285714	0.6680635453568746
PSEUDOXANTHOMA ELASTICUM; PXE	0.0285714	0.6680635453568746
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.0285714	0.6680635453568746
STROKE, ISCHEMIC	0.0285714	0.6680635453568746
ALAGILLE SYNDROME 1; ALGS1	0.0285714	0.6680635453568746
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.028556326	0.6677110813585156
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02850509	0.6665130685271562
CRANIOSYNOSTOSIS 6; CRS6	0.028504111999999998	0.6664902006891307
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.028390961	0.6638444760056824
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.028339630999999997	0.6626442652430607
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.02819672	0.6593026848749131
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.028075433	0.656466722226051
OCULOCEREBROCUTANEOUS SYNDROME	0.028011826	0.6549794476112434
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.028005758	0.654837564133597
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.027963182	0.6538420415653253
HYPOMAGNESEMIA 2, RENAL	0.027942751	0.6533643188672712
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.027763028000000002	0.6491619912052674
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.027755781	0.6489925400578542
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.0277459	0.6487615000706058
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.0277459	0.6487615000706058
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.0277459	0.6487615000706058
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0277459	0.6487615000706058
RETT SYNDROME; RTT	0.027605851	0.6454868396947164
#602099 AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5	0.027427519999999997	0.6413170601211905
NAVAJO NEUROHEPATOPATHY	0.027398082	0.6406287335201764
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.02738091	0.640227213566626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.027362261	0.6397911580335629
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.02733743	0.6392105534466419
GAUCHER DISEASE, PERINATAL LETHAL	0.027294300999999997	0.6382021004955194
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.027278787000000002	0.637839348308274
TAY-SACHS DISEASE; TSD	0.027231551	0.6367348644667935
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.027231551	0.6367348644667935
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.027178656000000002	0.6354980604868817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.027159682	0.6350544057233908
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.027159682	0.6350544057233908
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.027127002999999997	0.6342902972583272
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.027074568	0.6330642491122516
PRADER-WILLI SYNDROME; PWS	0.027051573	0.6325265743316849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.02703444	0.6321259662857859
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.027027	0.631952002364611
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.027027	0.631952002364611
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.027027	0.631952002364611
#614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8;;CARDIOMYOPATHY, HYPERTROPHIC MITOCHONDRIAL, FATAL INFANTILE	0.027027	0.631952002364611
#607364 BARTTER SYNDROME, TYPE 3;;BARTTER SYNDROME, CLASSICBARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA, INCLUDED	0.027027	0.631952002364611
SPINOCEREBELLAR ATAXIA 18	0.02697327	0.6306956742080619
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.02693993	0.629916110077421
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.026895148	0.6288690062712311
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.026807642	0.6268229193241442
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.026732751	0.625071799428888
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.0266115	0.6222366785409349
KOOLEN-DE VRIES SYNDROME; KDVS	0.026444508	0.6183320302714683
RECOMBINANT CHROMOSOME 8 SYNDROME	0.026443877999999997	0.6183172994555624
KNOBLOCH SYNDROME 1; KNO1	0.026367971	0.616542423196877
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.026348286	0.6160821436554352
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.026331680000000003	0.6156938580539528
Oliver-McFarlane syndrome	0.026282714999999998	0.614548946306597
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.026240682	0.6135661202987016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.026229973	0.6133157198105481
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.02619511	0.6125005445170106
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.02615266	0.6115079681119202
Cerebral creatine deficiency syndrome 3	0.026078677	0.6097780792973666
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.02605382	0.6091968667720113
#605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;;NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;;SPINAL MUSCULAR ATROPHY, JERASH TYPE	0.02605382	0.6091968667720113
#614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	0.02605382	0.6091968667720113
MYOPATHY, DISTAL, INFANTILE-ONSET	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.02605382	0.6091968667720113
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.02605382	0.6091968667720113
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.026022162	0.6084566315816143
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.026000761	0.6079562281035145
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.02596376	0.6070910615648867
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.025929605	0.6062924409025578
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.025928892000000002	0.606275769360112
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.025822183000000002	0.6037806731148637
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.025480028000000002	0.5957803202318555
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.025209843	0.5894627876992442
BEEMER LETHAL MALFORMATION SYNDROME	0.025163360000000003	0.5883759106901084
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.02508501	0.5865439116008544
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.02508501	0.5865439116008544
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.025072063	0.5862411816428637
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.025015433	0.5849170449686524
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.025015433	0.5849170449686524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.024947477000000003	0.583328080959599
FRONTONASAL DYSPLASIA 2; FND2	0.024935135	0.5830394972613274
TYSHCHENKO SYNDROME	0.024836312	0.5807287934196255
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.024768151000000002	0.5791350360498407
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.024765808	0.5790802514440191
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.024637118000000003	0.5760711900171386
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.024621913	0.575715662944361
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.024608494999999998	0.5754019199478121
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.024608494999999998	0.5754019199478121
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.024562065	0.5743162821977923
HYPERMANGANESEMIA WITH DYSTONIA 2	0.024550757	0.5740518757434044
PETERS-PLUS SYNDROME; PTRPLS	0.024547203	0.573968775235897
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0243902	0.5702976922364057
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.0243902	0.5702976922364057
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.0243902	0.5702976922364057
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0243902	0.5702976922364057
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.024345003	0.5692408847975159
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.024099682	0.5635047284659923
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.023965728	0.560372582888431
MEND SYNDROME; MEND	0.023784788	0.5561417990312566
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.023763899999999998	0.5556533906461086
#610357 SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30	0.02371747	0.5545677528960888
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02368943	0.5539121146770374
SPINAL ARACHNOIDITIS	0.02368943	0.5539121146770374
NEPHROSIALIDOSIS	0.02368943	0.5539121146770374
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.023354983	0.5460919921575258
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.023344392	0.5458443507745738
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.0232558	0.5437728707067349
%109500 BASILAR IMPRESSION, PRIMARY	0.0232558	0.5437728707067349
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0232558	0.5437728707067349
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	0.5437728707067349
REFSUM DISEASE	0.0232558	0.5437728707067349
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.0232558	0.5437728707067349
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.023212153	0.5427523057514231
PHACE ASSOCIATION	0.023131763	0.5408726068773309
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.023067175	0.5393623942777555
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.02301541	0.5381520122374844
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.022988933	0.5375329204712281
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	0.5366115897741781
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	0.5366115897741781
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	0.5366115897741781
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	0.5366115897741781
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.022880266	0.5349920417854341
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.022868030999999997	0.5347059599876419
JABERI-ELAHI SYNDROME; JABELS	0.022836178	0.5339611652589883
WARBURG MICRO SYNDROME 1	0.022713125	0.5310839095610947
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.022675738	0.5302097174749436
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.022642943000000002	0.5294428966691735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.022574587	0.5278445797611321
Diamond-Blackfan anemia 1	0.022528305	0.5267624025837376
ROIFMAN SYNDROME; RFMN	0.022527592	0.5267457310412917
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.022377598	0.5232385342143159
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.022216012	0.5194602903746708
KAGAMI-OGATA SYNDROME	0.022167832999999998	0.5183337570738262
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.022147677999999997	0.5178624878760737
JOUBERT SYNDROME 14	0.022024442	0.5149809532268931
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.022010563	0.5146564310142605
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	0.5132936434849817
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.021782746	0.5093295575424472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.021760346	0.5088057951991252
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.021611257999999998	0.5053197826883568
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.021584928	0.5047041281124787
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.021540253000000002	0.5036595262067681
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021473617	0.5021014267643745
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.02144133	0.5013464841403191
SECKEL SYNDROME 7; SCKL7	0.021422061	0.5008959316138248
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.021368146	0.49963527774149386
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.02135409	0.49930661687105915
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.02127551	0.49746923986488717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.021252082	0.4969214405711661
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0212128	0.4960029391260599
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.021199998	0.4957035995939524
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.02118056	0.49524909546763557
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.02118056	0.49524909546763557
AASE-SMITH SYNDROME I	0.02118056	0.49524909546763557
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.02107623	0.4928096255891178
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.021057573	0.49237338299807487
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.020991146	0.49082017044540255
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.020990433	0.4908034989029566
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.020961708	0.49013184384438846
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.020961708	0.49013184384438846
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.020915751	0.48905726589742166
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.020904442999999998	0.4887928594430338
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.02088611	0.4883641927001712
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.020844595	0.48739347869646504
SPASTIC PARAPLEGIA 16, X-LINKED	0.020844595	0.48739347869646504
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.020833287	0.4871290722420772
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.020826033	0.4869594574189317
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.020821087000000002	0.4868438088229465
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.020535614999999997	0.48016883187326526
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020523551	0.47988674843979046
HHHH SYNDROME	0.020523551	0.47988674843979046
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.02050631	0.47948361511116466
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.02050631	0.47948361511116466
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.02050631	0.47948361511116466
VAN DEN BOSCH SYNDROME	0.020452395	0.4782229612388338
MICROPHTHALMIA, SYNDROMIC 4	0.020452395	0.4782229612388338
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	0.47718958281190865
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	0.47718958281190865
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	0.47718958281190865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	0.47718958281190865
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	0.47718958281190865
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	0.47718958281190865
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	0.47718958281190865
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	0.47718958281190865
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	0.47718958281190865
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	0.47718958281190865
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	0.47718958281190865
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	0.47718958281190865
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	0.47718958281190865
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	0.47718958281190865
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.020265455999999998	0.47385190727908827
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.02026146	0.47375847181819924
RHABDOMYOLYSIS, ACUTE RECURRENT	0.02026146	0.47375847181819924
XFE PROGEROID SYNDROME; XFEPS	0.02025605	0.47363197385938804
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.020213929999999998	0.47264711359596256
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.020198107	0.472277136294249
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.020146551	0.47107164114369915
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.020146551	0.47107164114369915
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.020146551	0.47107164114369915
MENTAL RETARDATION, X-LINKED 103	0.020119568	0.47044071796022324
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.020117826000000002	0.470399986085131
ZECHI-CEIDE SYNDROME	0.020075395	0.4694078539427425
LEBER CONGENITAL AMAUROSIS, TYPE II	0.020075395	0.4694078539427425
JOUBERT SYNDROME 35; JBTS35	0.020074682	0.46939118240029654
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.020074682	0.46939118240029654
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.020074682	0.46939118240029654
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.02	0.46764494939476153
#603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	0.02	0.46764494939476153
#162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF	0.02	0.46764494939476153
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.02	0.46764494939476153
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.02	0.46764494939476153
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.02	0.46764494939476153
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.02	0.46764494939476153
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.02	0.46764494939476153
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.02	0.46764494939476153
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.02	0.46764494939476153
#610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	0.02	0.46764494939476153
AMYOTROPHIC LATERAL SCLEROSIS 3	0.02	0.46764494939476153
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.02	0.46764494939476153
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.02	0.46764494939476153
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.02	0.46764494939476153
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.02	0.46764494939476153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019988692	0.4673805429403737
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.019910282	0.46554714091627164
Helsmoortel-van der Aa syndrome	0.019845628	0.4640353850883632
PEROXISOME BIOGENESIS DISORDER 14B	0.01984126	0.46393325143141534
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.019701843	0.4606733686359269
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.019617446	0.4586999770962234
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.4584744319371304
TRACHEOBRONCHOMEGALY	0.0196078	0.4584744319371304
#215300 CHONDROSARCOMA	0.0196078	0.4584744319371304
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.4584744319371304
CARPAL DISPLACEMENT	0.0196078	0.4584744319371304
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.4584744319371304
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.4584744319371304
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	0.4584744319371304
PUBIC BONE DYSPLASIA	0.0196078	0.4584744319371304
MEGAEPIPHYSEAL DWARFISM	0.0196078	0.4584744319371304
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.4584744319371304
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.4584744319371304
MONOPHALANGY OF GREAT TOE	0.0196078	0.4584744319371304
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.4584744319371304
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.4584744319371304
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.4584744319371304
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.4584744319371304
THROMBOCYTOPENIA 3	0.0196078	0.4584744319371304
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.4584744319371304
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.4584744319371304
TOE, MISSHAPEN	0.0196078	0.4584744319371304
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.4584744319371304
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.4584744319371304
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.4584744319371304
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.4584744319371304
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.4584744319371304
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.4584744319371304
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.4584744319371304
RAYNAUD DISEASE	0.0196078	0.4584744319371304
KNUCKLE PADS	0.0196078	0.4584744319371304
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.4584744319371304
VESICOURETERAL REFLUX 1	0.0196078	0.4584744319371304
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.019593448	0.4581388499214446
PELGER-HUET ANOMALY; PHA	0.019545577	0.45701951835282084
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.019439873000000003	0.4545479212662797
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.019432661	0.45437928849752784
MASA SYNDROME	0.019412755	0.45391384147939523
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.019361505	0.4527155012965712
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.019339120999999997	0.4521921130692085
INFANTILE LIVER FAILURE SYNDROME 2	0.019273231000000002	0.45065145678342755
HYPOADRENOCORTICISM, FAMILIAL	0.019273231000000002	0.45065145678342755
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.0192308	0.449659324641039
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.0192308	0.449659324641039
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.0192308	0.449659324641039
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.0192308	0.449659324641039
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0192308	0.449659324641039
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.0192308	0.449659324641039
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.0192308	0.449659324641039
#614844 NEPHRONOPHTHISIS 14; NPHP14JOUBERT SYNDROME 19, INCLUDED; JBTS19, INCLUDED	0.0192308	0.449659324641039
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0192308	0.449659324641039
CYCLIC VOMITING SYNDROME	0.019193496	0.448787073281428
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.019080606	0.4461474513645692
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.018916910000000002	0.44231987098276304
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.018882186000000002	0.4415079458216238
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	0.4411739070342711
269800 SENILE PLAQUE FORMATION	0.0188679	0.4411739070342711
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.4411739070342711
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.4411739070342711
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.4411739070342711
RHEUMATOID ARTHRITIS	0.0188679	0.4411739070342711
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.4411739070342711
MYOPATHY, CONGENITAL	0.0188679	0.4411739070342711
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.4411739070342711
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.4411739070342711
ALCOHOL DEPENDENCE	0.0188679	0.4411739070342711
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.4411739070342711
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.4411739070342711
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.4411739070342711
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.4411739070342711
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.4411739070342711
CERVICAL RIB	0.0188679	0.4411739070342711
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.4411739070342711
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.4411739070342711
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.4411739070342711
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.4411739070342711
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.4411739070342711
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.4411739070342711
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.4411739070342711
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.4411739070342711
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.4411739070342711
MOTION SICKNESS	0.0188679	0.4411739070342711
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.4411739070342711
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.4411739070342711
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.4411739070342711
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.4411739070342711
JUMPING FRENCHMAN OF MAINE	0.0188679	0.4411739070342711
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.4411739070342711
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.4411739070342711
CARDIAC ARRHYTHMIA	0.0188679	0.4411739070342711
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.4411739070342711
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.4411739070342711
DIASTEMATOMYELIA	0.0188679	0.4411739070342711
PALMOMENTAL REFLEX	0.0188679	0.4411739070342711
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.4411739070342711
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.4411739070342711
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.4411739070342711
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.4411739070342711
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.4411739070342711
#278250 WRINKLY SKIN SYNDROME; WSS	0.018786805	0.43927772367571266
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.018700982	0.4372709890511174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01864287	0.4359121998861559
Glycosylphosphatidylinositol biosynthesis defect 18	0.018517313	0.432976395040598
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01851691	0.4329669719948677
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.01851691	0.4329669719948677
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.018426333	0.43084907816580126
SHASHI-PENA SYNDROME; SHAPNS	0.018410168	0.4304711041354529
257960 OCULOTRICHODYSPLASIA; OTD	0.01836733	0.4294694554183443
DERMATITIS, ATOPIC	0.01836733	0.4294694554183443
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.018357480000000002	0.4292391402807674
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.018357480000000002	0.4292391402807674
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.018279043000000002	0.42740510693598355
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018246913	0.4266538353247809
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.018218403	0.42598720744941865
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.018137245	0.4240895510092696
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.018085312	0.42287524075142363
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018085282	0.42287453928399965
ALSTROM SYNDROME; ALMS	0.018085282	0.42287453928399965
SILVER-RUSSELL SYNDROME; SRS	0.018085282	0.42287453928399965
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.018085282	0.42287453928399965
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.017998390000000003	0.4208428090368592
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.017998390000000003	0.4208428090368592
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.017934738	0.41935448222091537
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0178571	0.4175391312918599
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.0178571	0.4175391312918599
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.0178571	0.4175391312918599
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.0178571	0.4175391312918599
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.0178571	0.4175391312918599
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.0178571	0.4175391312918599
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.017809323000000002	0.4164219976544982
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.017720529999999998	0.4143458177549177
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.017720529999999998	0.4143458177549177
INCLUSION BODY MYOSITIS	0.017720529999999998	0.4143458177549177
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.017720529999999998	0.4143458177549177
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.017653216	0.41277186514873976
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.017529628	0.4098820999484497
MENTAL RETARDATION, X-LINKED 98; MRX98	0.017529628	0.4098820999484497
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.017529628	0.4098820999484497
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.01751534	0.40954801439660216
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.017510582	0.40943676166314114
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.017510582	0.40943676166314114
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.017501943	0.40923476242725004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.017430508	0.40756445157924936
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.017385346	0.40650846251902106
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.017321556000000002	0.4050169089529264
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.017313477	0.4048280037756184
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.017265607999999998	0.40370871897148947
EPISODIC ATAXIA, TYPE 6	0.017264961	0.4036935906573766
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017249687	0.4033364502095238
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0172414	0.4031426815247421
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0172414	0.4031426815247421
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0172414	0.4031426815247421
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.0172414	0.4031426815247421
#245590 GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;;LARON SYNDROME DUE TO POSTRECEPTOR DEFECT;;GROWTH HORMONE INSENSITIVITY DUE TO POSTRECEPTOR DEFECT	0.0172414	0.4031426815247421
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0172414	0.4031426815247421
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.017090143000000002	0.39960595291921197
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.01704986	0.39866404584438847
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01704986	0.39866404584438847
BETHLEM MYOPATHY 2; BTHLM2	0.01704986	0.39866404584438847
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.017033022	0.39827033556149294
MENTAL RETARDATION, X-LINKED 1	0.016685745999999998	0.39015024218919225
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.016685033	0.3901335706467463
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.016685033	0.3901335706467463
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.01666666	0.3897039686139848
ZTTK SYNDROME; ZTTKS	0.016630428	0.3888567830236613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01662444	0.3887167701258125
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.016613877	0.38846978344578964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.016585913	0.3878159222775459
PACHYGYRIA, FRONTOTEMPORAL	0.016540751	0.3867599332173176
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.016469595	0.3850961460163609
ELLIS-VAN CREVELD SYNDROME	0.016469595	0.3850961460163609
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.016468882	0.385079474473915
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.016466246	0.3850178388695848
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.016465532999999997	0.3850011673271388
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.016405805	0.3836045924502663
HALLERMANN-STREIFF SYNDROME; HSS	0.016405805	0.3836045924502663
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.016405092	0.3835879209078204
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.016405092	0.3835879209078204
ANIRIDIA	0.016404730000000003	0.3835794565342364
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.016360712	0.3825502167651134
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.016341815000000003	0.38210836243467783
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016055652	0.3754172283519951
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.015922412	0.37230177769912726
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.015845508	0.3705035893397145
PALLISTER-KILLIAN SYNDROME	0.015841150999999998	0.3704017128874888
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.015825236	0.37002958441900796
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.015769995	0.36873792568653213
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.015769282	0.3687212541440862
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015769282	0.3687212541440862
EMANUEL SYNDROME	0.015765008	0.36862131841840057
WIEACKER-WOLFF SYNDROME	0.015729133	0.3677824802904237
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.015726205	0.3677140170698323
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.015721405	0.3676017822819776
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.015644438	0.36580212084097424
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.015625	0.3653476167146575
DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT	0.015625	0.3653476167146575
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.015625	0.3653476167146575
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.015621650999999999	0.3652693095678813
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.015621650999999999	0.3652693095678813
IMMUNODEFICIENCY 55; IMD55	0.01556121	0.3638560631485629
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.01556121	0.3638560631485629
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.015534336	0.3632276886300611
DYSTONIA 23; DYT23	0.015482170000000002	0.3620079303085548
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.015482170000000002	0.3620079303085548
SPINOCEREBELLAR ATAXIA 12	0.015482170000000002	0.3620079303085548
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.015443643	0.36110708246028816
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.015374038	0.35947956112515705
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.015374038	0.35947956112515705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.015374038	0.35947956112515705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.015310403	0.35799163180742033
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.015252073000000001	0.35662774531251046
BARBER-SAY SYNDROME; BBRSAY	0.015130295	0.3537803019801407
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.015130295	0.3537803019801407
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.015079370000000002	0.35258956102774436
MYOPATHY, DISTAL, 4; MPD4	0.015079370000000002	0.35258956102774436
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.015070771	0.352388497081752
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.015031683	0.35147453179265487
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.014990838000000001	0.35051948389475346
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.014945891	0.3494685220177311
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.014909485	0.34861726791634784
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.014849999999999999	0.3472263749256104
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.014800556000000001	0.34607026308171673
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.014717202	0.3441212592261242
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0147059	0.34385699306522116
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.34385699306522116
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0147059	0.34385699306522116
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0147059	0.34385699306522116
RAGWEED SENSITIVITY	0.0147059	0.34385699306522116
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.34385699306522116
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.34385699306522116
STIFF-PERSON SYNDROME; SPS	0.0147059	0.34385699306522116
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.34385699306522116
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0147059	0.34385699306522116
PSORIASIS 14, PUSTULAR	0.0147059	0.34385699306522116
CYCLIC NEUTROPENIA	0.0147059	0.34385699306522116
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0147059	0.34385699306522116
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.0147059	0.34385699306522116
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.34385699306522116
CIRRHOSIS, FAMILIAL	0.0147059	0.34385699306522116
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.0147059	0.34385699306522116
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.0147059	0.34385699306522116
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.34385699306522116
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.34385699306522116
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.34385699306522116
PANCREATITIS, HEREDITARY	0.0147059	0.34385699306522116
IMMUNODEFICIENCY 32B; IMD32B	0.0147059	0.34385699306522116
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.0147059	0.34385699306522116
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.34385699306522116
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.34385699306522116
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0147059	0.34385699306522116
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.0147059	0.34385699306522116
CINCA SYNDROME; CINCA	0.0147059	0.34385699306522116
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0147059	0.34385699306522116
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.0147059	0.34385699306522116
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.0147059	0.34385699306522116
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.0147059	0.34385699306522116
CAFFEY DISEASE	0.0147059	0.34385699306522116
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.34385699306522116
HALOTHANE HEPATITIS	0.0147059	0.34385699306522116
DYSTONIA 12; DYT12	0.0147059	0.34385699306522116
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.014689741	0.34347915932835765
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.014580133000000002	0.34091627794769475
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.014556253	0.3403579098781173
GABA-TRANSAMINASE DEFICIENCY	0.014549013	0.34018862240643644
NIEMANN-PICK DISEASE, TYPE A	0.014490417	0.33881851623369963
GLYCOGEN STORAGE DISEASE IXA	0.0144668	0.33826629769520683
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.014458287	0.338067244622497
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.014458287	0.338067244622497
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.014408191	0.33689588755325295
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.014368928000000001	0.33597783037084866
DERMOODONTODYSPLASIA	0.0142857	0.3340317726784373
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.0142857	0.3340317726784373
TOOTH AGENESIS, SELECTIVE, 4	0.0142857	0.3340317726784373
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.0142857	0.3340317726784373
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.0142857	0.3340317726784373
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.0142857	0.3340317726784373
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0142857	0.3340317726784373
ABLEPHARON-MACROSTOMIA SYNDROME	0.0142857	0.3340317726784373
CRANIOECTODERMAL DYSPLASIA 3	0.0142857	0.3340317726784373
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0142857	0.3340317726784373
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.0142857	0.3340317726784373
HELIX SYNDROME; HELIX	0.0142857	0.3340317726784373
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.0142857	0.3340317726784373
190360 TRICHODYSPLASIA-XERODERMA	0.0142857	0.3340317726784373
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.0142857	0.3340317726784373
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.0142857	0.3340317726784373
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.0142857	0.3340317726784373
#614640 UV-SENSITIVE SYNDROME 3; UVSS3	0.0142857	0.3340317726784373
#129490 ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT;ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	0.0142857	0.3340317726784373
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.0142857	0.3340317726784373
#600630 UV-SENSITIVE SYNDROME 1; UVSS1	0.0142857	0.3340317726784373
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.0142857	0.3340317726784373
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.0142857	0.3340317726784373
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.0142857	0.3340317726784373
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0142857	0.3340317726784373
#611554 LEOPARD SYNDROME 2	0.0142857	0.3340317726784373
#300640 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	0.0142857	0.3340317726784373
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.014258825999999999	0.33340339815993547
CODAS SYNDROME	0.014238998	0.3329397749571055
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.01415502	0.33097618057909195
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.014146243000000001	0.33077095459305
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.014146243000000001	0.33077095459305
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.014098527999999999	0.3296552706550314
SCHAAF-YANG SYNDROME; SHFYNG	0.014098527999999999	0.3296552706550314
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.014098527999999999	0.3296552706550314
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.014096010000000003	0.3295963941559027
GAPO SYNDROME; GAPOS	0.013892516	0.32483824708929576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.013884092	0.3246412750366107
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013884092	0.3246412750366107
TIMOTHY SYNDROME; TS	0.013715328	0.3206951934246278
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.013712371	0.32062605211885975
DIAPHANOSPONDYLODYSOSTOSIS	0.013664382000000003	0.31950396144503457
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.013646535000000001	0.3190866584744421
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.013644903	0.3190484986465715
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.013641215000000002	0.3189622649179032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.013640501999999999	0.3189455933754572
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.013613692	0.31831871532079353
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.013613692	0.31831871532079353
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.01360544	0.3181257650146732
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.01360544	0.3181257650146732
STURGE-WEBER SYNDROME	0.013525046	0.3162459726115911
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.013513561	0.31597742749940116
TEMTAMY SYNDROME; TEMTYS	0.013496722999999999	0.3155837172165057
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.013477112999999999	0.31512519134362416
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.013452921	0.31455952801283626
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.013441692	0.31429696875599855
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.01329402	0.3108440655076474
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.013253932999999999	0.309906741353328
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013253932999999999	0.309906741353328
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.013182777	0.30824295415237135
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.013182777	0.30824295415237135
COFFIN-SIRIS SYNDROME 7; CSS7	0.013182777	0.30824295415237135
Retinitis pigmentosa with or without skeletal anomalies	0.013182777	0.30824295415237135
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01291028	0.30187136186361013
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.01287951	0.3011518901089663
MYASTHENIC SYNDROME, CONGENITAL, 13	0.01287951	0.3011518901089663
#613158 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2N; LGMD2N;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMT2-RELATED	0.01287951	0.3011518901089663
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.012871446	0.3009633356653703
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.012870733	0.30094666412292437
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.012870733	0.30094666412292437
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.012820500000000002	0.29977210368577706
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.012810113000000001	0.2995292322813089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.012810113000000001	0.2995292322813089
EPISODIC ATAXIA, TYPE 3	0.012801940000000001	0.2993381291727387
LYSINURIC PROTEIN INTOLERANCE; LPI	0.012801940000000001	0.2993381291727387
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.012801940000000001	0.2993381291727387
VALINEMIA	0.012801940000000001	0.2993381291727387
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.012799577000000001	0.29928287692196776
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.012793988	0.2991521935408593
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.012680451	0.2964974433098877
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.012597810000000001	0.2945651109967411
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.012597810000000001	0.2945651109967411
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.012561362	0.29371287484096403
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.012556210000000002	0.293592409502
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.012550520999999999	0.29345938789614456
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.012338182	0.2884944248506679
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.012338182	0.2884944248506679
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.012338182	0.2884944248506679
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012338182	0.2884944248506679
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.012314957000000001	0.2879513721531833
HADZISELIMOVIC SYNDROME	0.012295347	0.28749284628030164
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.012180778	0.2848139655699412
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.012068828	0.28219632296570407
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.012026851	0.28121480636366686
FRUCTOSE AND GALACTOSE INTOLERANCE	0.012026851	0.28121480636366686
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.012010746	0.2808382352681667
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.011955695	0.2795510191627102
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.011954982000000001	0.2795343476202643
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.011954982000000001	0.2795343476202643
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.011954982000000001	0.2795343476202643
XQ25 DUPLICATION SYNDROME	0.011935588	0.2790808723128362
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.01191419	0.2785805389814787
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.01183028	0.27661853459629304
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.011816618000000001	0.27629908633136147
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.011764700000000001	0.27508512680722763
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.011764700000000001	0.27508512680722763
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.011764700000000001	0.27508512680722763
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.011764700000000001	0.27508512680722763
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.011764700000000001	0.27508512680722763
CEREBROCORTICAL DEGENERATION OF INFANCY	0.011764700000000001	0.27508512680722763
ALZHEIMER DISEASE 10	0.011764700000000001	0.27508512680722763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.011737089999999999	0.27443954295458806
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.011717479999999999	0.2739810170817065
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011683378000000001	0.2731836356784935
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.011683378000000001	0.2731836356784935
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.011552419999999999	0.2701215433143515
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.011552419999999999	0.2701215433143515
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.011552419999999999	0.2701215433143515
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.011552419999999999	0.2701215433143515
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.011552419999999999	0.2701215433143515
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.011494299999999999	0.2687625670914104
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.011494299999999999	0.2687625670914104
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.011494299999999999	0.2687625670914104
CRANIOFRONTONASAL SYNDROME; CFNS	0.011470362	0.2682028428514798
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.011447453	0.26766717894419556
Congenital disorder of glycosylation, type IIh	0.011376297	0.2660033917432389
ASPARTYLGLUCOSAMINURIA; AGU	0.011336895999999999	0.2650821078106837
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.011336895999999999	0.2650821078106837
MENTAL RETARDATION, X-LINKED 102	0.011314926	0.26456839983377356
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.011314213	0.26455172829132767
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.011283443	0.26383225653668385
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.011212287000000001	0.2621684693357272
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.0111111	0.2598024898610068
GLYCOGEN STORAGE DISEASE IA	0.0111111	0.2598024898610068
GLYCOGEN STORAGE DISEASE IB	0.0111111	0.2598024898610068
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.0111111	0.2598024898610068
GLYCOGEN STORAGE DISEASE VI	0.0111111	0.2598024898610068
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.0111111	0.2598024898610068
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.0111111	0.2598024898610068
HEMOCHROMATOSIS, NEONATAL	0.0111111	0.2598024898610068
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.0111111	0.2598024898610068
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.0111111	0.2598024898610068
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.0111111	0.2598024898610068
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0111111	0.2598024898610068
RIBOFLAVIN DEFICIENCY	0.0111111	0.2598024898610068
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0111111	0.2598024898610068
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.0111111	0.2598024898610068
TYROSINEMIA, TYPE I; TYRSN1	0.0111111	0.2598024898610068
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.0111111	0.2598024898610068
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.01105048	0.25838505801939127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.011033642	0.2579913477364958
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.010972736	0.25656722857210396
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.010972023000000001	0.25655055702965807
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.010972023000000001	0.25655055702965807
XYLOSIDASE DEFICIENCY	0.010967731	0.2564502004235179
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.01096385	0.25635945392108783
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010921988	0.2553806262775097
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.010838783000000001	0.2534351063767901
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010838783000000001	0.2534351063767901
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.010828266999999999	0.2531892186623983
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.010800948	0.25255043904377256
SPINOCEREBELLAR ATAXIA 23; SCA23	0.01075972	0.2515864357450902
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010673882999999999	0.24957937376903025
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.010670893	0.24950946084909578
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010594685000000001	0.247727546533922
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.010541108	0.2464747958612358
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.010541108	0.2464747958612358
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.010541108	0.2464747958612358
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.010439561	0.24410039877742631
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.010407868	0.24335934520836794
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.010398462	0.24313941178866755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.010281523	0.2404051151518039
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010281523	0.2404051151518039
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0102504	0.2396773894638032
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.010234213	0.23929890102401055
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.010116912	0.23655614001356282
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.010109026	0.23637174761001645
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.010077393	0.23563209697580623
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010038703	0.23472743782120206
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.009994901	0.23370324861753258
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.009975786	0.23325629695714856
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.009957065999999999	0.23281858128451502
GILLESPIE SYNDROME; GLSP	0.009947425	0.23259315303665928
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.009903916999999998	0.23157583821374592
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.009850608	0.23032935398338167
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.009774970000000001	0.22856076754926563
#612900 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	0.009758844999999999	0.22818372880881607
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.009755855	0.2281138158888816
EDINBURGH MALFORMATION SYNDROME	0.009755855	0.2281138158888816
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009755142	0.22809714434643566
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.009739016999999999	0.2277201056059861
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.009696513	0.2267262665595324
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.009696513	0.2267262665595324
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.009646478	0.22555633580738405
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00963719	0.22533916149288513
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00963719	0.22533916149288513
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00963719	0.22533916149288513
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.009626868	0.22509780993450246
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.009625357000000001	0.2250624793585757
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.009563273	0.22361081590666448
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.009563273	0.22361081590666448
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.009557435	0.22347431034593612
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00952381	0.22268808227476622
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.00952381	0.22268808227476622
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.00952381	0.22268808227476622
OPTIC ATROPHY 1; OPA1	0.00952381	0.22268808227476622
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.00952381	0.22268808227476622
SPINAL MUSCULAR ATROPHY, TYPE IV	0.00952381	0.22268808227476622
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00952381	0.22268808227476622
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00952381	0.22268808227476622
MYOSITIS	0.00952381	0.22268808227476622
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00952381	0.22268808227476622
AXIAL OSTEOMALACIA	0.00952381	0.22268808227476622
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00952381	0.22268808227476622
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.00952381	0.22268808227476622
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00952381	0.22268808227476622
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.00952381	0.22268808227476622
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.00952381	0.22268808227476622
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00952381	0.22268808227476622
CARDIOMYOPATHY, DILATED, 1X	0.00952381	0.22268808227476622
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00952381	0.22268808227476622
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.00952381	0.22268808227476622
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00952381	0.22268808227476622
#612999 EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5	0.00952381	0.22268808227476622
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.0094646	0.221303619402083
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.009437641	0.22067325739254634
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.009319175	0.21790325606379635
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00927303	0.21682428225430528
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00927303	0.21682428225430528
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00927303	0.21682428225430528
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00927303	0.21682428225430528
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00927303	0.21682428225430528
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.009263587	0.21660348369144855
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.009162355	0.21423645201559205
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.009162355	0.21423645201559205
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.009131191	0.21350776765544513
PITT-HOPKINS SYNDROME	0.009131191	0.21350776765544513
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.009006013	0.21058082468167824
METHYLMALONIC ACIDURIA, CBLA TYPE	0.009006013	0.21058082468167824
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.008990177	0.21021054341074746
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008934857000000001	0.20891703748072157
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.008914249999999999	0.20843519950711262
#615731 NEMALINE MYOPATHY 9; NEM9	0.00891126	0.20836528658717815
SENGERS SYNDROME	0.00891126	0.20836528658717815
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00891126	0.20836528658717815
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00891126	0.20836528658717815
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00891126	0.20836528658717815
SOTOS SYNDROME 2	0.008895134999999998	0.20798824784672856
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.008852631	0.20699440880027487
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.008852631	0.20699440880027487
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.008833516	0.2065474571398908
GLYCINE ENCEPHALOPATHY; GCE	0.008802596	0.2058244780481265
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.008802596	0.2058244780481265
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.008801883	0.2058078065056806
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.008801883	0.2058078065056806
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.008781475	0.2053306215993182
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.008780762000000001	0.2053139500568723
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.008780762000000001	0.2053139500568723
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.008730727	0.20414401930472395
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.008711117	0.20368549343184236
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.008648235	0.2022151709464503
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.008647522	0.20219849940400436
SUPRABULBAR PARESIS, CONGENITAL	0.008591416000000001	0.20088661502746727
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.008590703000000002	0.20086994348502135
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.008590703	0.20086994348502132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.008574578	0.2004929047445718
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.008574578	0.2004929047445718
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.008574578	0.2004929047445718
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.008519547	0.19920615628406463
MELKERSSON-ROSENTHAL SYNDROME	0.00847458	0.19815472676209295
#615325 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R	0.00847458	0.19815472676209295
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00847458	0.19815472676209295
FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL	0.00847458	0.19815472676209295
SCLEROSTEOSIS 1; SOST1	0.00847458	0.19815472676209295
DUANE-RADIAL RAY SYNDROME; DRRS	0.00847458	0.19815472676209295
CRANIAL NERVES, RECURRENT PARESIS OF	0.00847458	0.19815472676209295
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00847458	0.19815472676209295
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00847458	0.19815472676209295
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00847458	0.19815472676209295
MYOPATHY, DISTAL, 5; MPD5	0.00847458	0.19815472676209295
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00847458	0.19815472676209295
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00847458	0.19815472676209295
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00847458	0.19815472676209295
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00847458	0.19815472676209295
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00847458	0.19815472676209295
#615348 NEMALINE MYOPATHY 8; NEM8	0.00847458	0.19815472676209295
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00847458	0.19815472676209295
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.00847458	0.19815472676209295
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00847458	0.19815472676209295
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00847458	0.19815472676209295
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00847458	0.19815472676209295
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00847458	0.19815472676209295
SCLEROSTEOSIS 2; SOST2	0.00847458	0.19815472676209295
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.00847458	0.19815472676209295
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.00847458	0.19815472676209295
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00847458	0.19815472676209295
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.008301039999999999	0.19409697153619454
WELANDER DISTAL MYOPATHY; WDM	0.00819672	0.19165773548015147
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00819672	0.19165773548015147
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00819672	0.19165773548015147
#608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	0.00819672	0.19165773548015147
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00819672	0.19165773548015147
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00819672	0.19165773548015147
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00819672	0.19165773548015147
#607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE	0.00819672	0.19165773548015147
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00819672	0.19165773548015147
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.00819672	0.19165773548015147
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.00819672	0.19165773548015147
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.00819672	0.19165773548015147
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00819672	0.19165773548015147
#611895 AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9	0.00819672	0.19165773548015147
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00819672	0.19165773548015147
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00819672	0.19165773548015147
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00819672	0.19165773548015147
#602433 AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES	0.00819672	0.19165773548015147
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.00819672	0.19165773548015147
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00819672	0.19165773548015147
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00819672	0.19165773548015147
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00819672	0.19165773548015147
AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES	0.00819672	0.19165773548015147
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.00819672	0.19165773548015147
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.008162131	0.19084896692242073
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.008162131	0.19084896692242073
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.008162131	0.19084896692242073
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.008146295	0.19047868565148995
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.008145582	0.19046201410904404
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.008099148	0.18937628283003424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.008099148	0.18937628283003424
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.008090975	0.18918517972146406
CHYLOMICRON RETENTION DISEASE	0.008090975	0.18918517972146406
HYPERCALCEMIA, INFANTILE, 1	0.008090975	0.18918517972146406
ALPHA-METHYLACETOACETIC ACIDURIA	0.008090975	0.18918517972146406
GALACTOSEMIA	0.008090975	0.18918517972146406
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.008090262	0.18916850817901815
METHYLMALONIC ACIDURIA, CBLB TYPE	0.008090262	0.18916850817901815
CHROMOSOME 10Q26 DELETION SYNDROME	0.007961368	0.18615467677365372
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00793688	0.18558209229761477
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00793688	0.18558209229761477
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00793688	0.18558209229761477
BEHR SYNDROME	0.007917765	0.18513514063723072
SPINOCEREBELLAR ATAXIA 13	0.007917765	0.18513514063723072
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.007917765	0.18513514063723072
OROFACIODIGITAL SYNDROME V; OFD5	0.007886845	0.1844121615454664
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.007886845	0.1844121615454664
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.007886845	0.1844121615454664
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.007886132	0.1843954900030205
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.007886132	0.1843954900030205
MENTAL RETARDATION, X-LINKED 12; MRX12	0.007867235	0.18395363567258485
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.007866522	0.18393696413013894
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.007866522	0.18393696413013894
%300712 CRANIOFACIOSKELETAL SYNDROME	0.007866522	0.18393696413013894
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.007866522	0.18393696413013894
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.007866522	0.18393696413013894
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.007866522	0.18393696413013894
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.007855681	0.1836834771853195
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.007730696	0.18076104698531428
COFFIN-LOWRY SYNDROME; CLS	0.007730696	0.18076104698531428
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.007730696	0.18076104698531428
MACDERMOT-WINTER SYNDROME	0.007729982999999999	0.18074437544286837
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.007675665	0.17947429852480712
ROBERTS SYNDROME; RBS	0.007675665	0.17947429852480712
Mental retardation, autosomal dominant 21	0.007658827	0.1790805882419117
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.007597208000000001	0.17763979753507392
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.007597208000000001	0.17763979753507392
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.007597208000000001	0.17763979753507392
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.007597207999999999	0.17763979753507386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0074639680000000005	0.174524346882206
EHLERS-DANLOS SYNDROME, TYPE VI	0.00743733	0.1739014905741071
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0074356069999999995	0.17386120296171673
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.0074356069999999995	0.17386120296171673
NEURAMINIDASE DEFICIENCY	0.0073159060000000005	0.17106232455734163
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.007315193	0.17104565301489572
GRACILE BONE DYSPLASIA; GCLEB	0.007315193	0.17104565301489572
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0073016999999999995	0.17073015634978653
RENPENNING SYNDROME 1; RENS1	0.007255266	0.1696444250707767
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.007254553	0.1696277535283308
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.007254553	0.1696277535283308
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.007254553	0.1696277535283308
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.007254553	0.1696277535283308
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.16943665041976064
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00724638	0.16943665041976064
PORPHYRIA VARIEGATA	0.00724638	0.16943665041976064
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.16943665041976064
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.16943665041976064
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.16943665041976064
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.16943665041976064
VISCERAL MYOPATHY; VSCM	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.16943665041976064
HYPERLIPOPROTEINEMIA, TYPE I	0.00724638	0.16943665041976064
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.16943665041976064
HYPER-IGD SYNDROME	0.00724638	0.16943665041976064
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.16943665041976064
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.16943665041976064
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.16943665041976064
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.16943665041976064
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.16943665041976064
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.16943665041976064
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.16943665041976064
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.16943665041976064
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.16943665041976064
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00724638	0.16943665041976064
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.16943665041976064
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00724638	0.16943665041976064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00724638	0.16943665041976064
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.16943665041976064
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00724638	0.16943665041976064
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.16943665041976064
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.16943665041976064
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.16943665041976064
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.16943665041976064
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.16943665041976064
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00724638	0.16943665041976064
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00724638	0.16943665041976064
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.16943665041976064
LIVER FAILURE, INFANTILE, TRANSIENT	0.00724638	0.16943665041976064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00724638	0.16943665041976064
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.16943665041976064
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.00724638	0.16943665041976064
HURLER SYNDROME	0.007244037	0.16938186581393902
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.007244037	0.16938186581393902
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007235438	0.16918080186794673
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.007235437999999999	0.1691808018679467
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.007183397	0.16796396632737412
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00707317	0.1653866113355273
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00707317	0.1653866113355273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00707317	0.1653866113355273
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00707317	0.1653866113355273
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00707317	0.1653866113355273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00707317	0.1653866113355273
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00707317	0.1653866113355273
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.00707317	0.1653866113355273
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00707317	0.1653866113355273
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.16466363224376296
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.00704225	0.16466363224376296
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.16466363224376296
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00704225	0.16466363224376296
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0069399299999999995	0.16227116068265937
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.006823638	0.1595519923599086
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.006823638	0.1595519923599086
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.006814944999999999	0.15934873048265416
FILIPPI SYNDROME; FLPIS	0.0067533260000000005	0.15790793977581638
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.006752613000000001	0.15789126823337046
SALLA DISEASE	0.006685858	0.15633038630352808
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.006685858	0.15633038630352808
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.006681457	0.15622748103241377
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.006662881	0.1557931324034159
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.006662881	0.1557931324034159
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0066193730000000004	0.15477581758050257
Xq28 (MECP2) duplication	0.0066193730000000004	0.15477581758050257
POTOCKI-LUPSKI SYNDROME	0.0066193730000000004	0.15477581758050257
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.006619373	0.15477581758050254
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.006619373	0.15477581758050254
SWEENEY-COX SYNDROME; SWCOS	0.006591011999999999	0.1541126736600133
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.006548217	0.15311203037954588
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.006548217	0.15311203037954588
ALEXANDER DISEASE	0.006471311	0.1513137952556382
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.006471311	0.1513137952556382
GAUCHER DISEASE, TYPE IIIC	0.006471311	0.1513137952556382
MUCOPOLYSACCHARIDOSIS, TYPE II	0.006471311	0.1513137952556382
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.006400155	0.1496500080546815
COWCHOCK SYNDROME; COWCK	0.006400155	0.1496500080546815
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.006400155	0.1496500080546815
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.006400155	0.1496500080546815
NEPHRONOPHTHISIS 18; NPHP18	0.006400155	0.1496500080546815
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.006400155	0.1496500080546815
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.006400155	0.1496500080546815
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.006400155	0.1496500080546815
CHANARIN-DORFMAN SYNDROME	0.006400155	0.1496500080546815
BIEMOND SYNDROME II	0.006400155	0.1496500080546815
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.006400155	0.1496500080546815
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.006400155	0.1496500080546815
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.006400155	0.1496500080546815
CHROMOSOME 17P13.1 DELETION SYNDROME	0.006399442	0.1496333365122356
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.006399442	0.1496333365122356
THANATOPHORIC DYSPLASIA, TYPE I	0.006399442	0.1496333365122356
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.006399442	0.1496333365122356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.006399442	0.1496333365122356
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.006399442	0.1496333365122356
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.006399442	0.1496333365122356
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0063915560000000005	0.14944894410868922
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0063915560000000005	0.14944894410868922
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.006391556	0.14944894410868922
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006390842999999999	0.14943227256624328
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.006338802	0.14821543702567067
OGDEN SYNDROME; OGDNS	0.006338802	0.14821543702567067
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.006338802	0.14821543702567067
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.006321698000000001	0.14781550706494828
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.006319686999999999	0.1477684853652866
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.006201735	0.14501050251173608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.006188458	0.14470005641208036
ZUNICH NEUROECTODERMAL SYNDROME	0.005979755999999999	0.13982013460065107
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.005979755999999999	0.13982013460065107
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.005979043	0.13980346305820518
HYPEREKPLEXIA 4; HKPX4	0.005979043	0.13980346305820518
GAUCHER DISEASE, TYPE II	0.005979043	0.13980346305820518
KETOADIPICACIDURIA	0.005959928	0.13935651139782113
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0058419760000000005	0.13659852854427057
EPILEPSY-TELANGIECTASIA	0.0058419760000000005	0.13659852854427057
HYPERLEUCINE-ISOLEUCINEMIA	0.0058419760000000005	0.13659852854427057
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.005841263	0.13658185700182465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005837575	0.13649562327315626
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.005836862	0.13647895173071034
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.005775491	0.13504395982124504
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.005770107	0.13491806980086796
EPILEPSY, PYRIDOXINE-DEPENDENT	0.005770107	0.13491806980086796
CEREBELLAR HYPOPLASIA	0.00574713	0.1343808159007558
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.00574713	0.1343808159007558
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.005703622	0.13336350107784245
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.005703622	0.13336350107784245
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.005703622	0.13336350107784245
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00555556	0.12990147875297808
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00555556	0.12990147875297808
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00555556	0.12990147875297808
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00555556	0.12990147875297808
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00555556	0.12990147875297808
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00555556	0.12990147875297808
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00555556	0.12990147875297808
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00555556	0.12990147875297808
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00555556	0.12990147875297808
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00555556	0.12990147875297808
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00555556	0.12990147875297808
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00555556	0.12990147875297808
KLEEBLATTSCHAEDEL SYNDROME	0.00555556	0.12990147875297808
SPINAL MUSCULAR ATROPHY, TYPE II	0.00555556	0.12990147875297808
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00555556	0.12990147875297808
#614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	0.00555556	0.12990147875297808
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.00555556	0.12990147875297808
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00555556	0.12990147875297808
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00555556	0.12990147875297808
CAMURATI-ENGELMANN DISEASE	0.00555556	0.12990147875297808
MUSCLE GLYCOGENOSIS, X-LINKED	0.00555556	0.12990147875297808
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00555556	0.12990147875297808
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00555556	0.12990147875297808
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00555556	0.12990147875297808
EPISODIC ATAXIA, TYPE 7; EA7	0.00555556	0.12990147875297808
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00555556	0.12990147875297808
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00555556	0.12990147875297808
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.00555556	0.12990147875297808
#168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC;;PARALYSIS PERIODICA PARAMYOTONICAPARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED	0.00555556	0.12990147875297808
RADIAL APLASIA, X-LINKED	0.00555556	0.12990147875297808
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00555556	0.12990147875297808
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00555556	0.12990147875297808
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00555556	0.12990147875297808
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00555556	0.12990147875297808
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00555556	0.12990147875297808
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00555556	0.12990147875297808
GLYCOGEN STORAGE DISEASE IV	0.00555556	0.12990147875297808
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.00555556	0.12990147875297808
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00555556	0.12990147875297808
EPISODIC ATAXIA, TYPE 8	0.00555556	0.12990147875297808
CAMPOMELIC DYSPLASIA	0.00555556	0.12990147875297808
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00555556	0.12990147875297808
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00555556	0.12990147875297808
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00555556	0.12990147875297808
SPONDYLOOCULAR SYNDROME; SOS	0.00555556	0.12990147875297808
#613507 GLYCOGEN STORAGE DISEASE XV; GSD15;;GSD XV;;GLYCOGENIN DEFICIENCY;;GYG1 DEFICIENCY	0.00555556	0.12990147875297808
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00555556	0.12990147875297808
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00555556	0.12990147875297808
STIFF SKIN SYNDROME	0.00555556	0.12990147875297808
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00555556	0.12990147875297808
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00555556	0.12990147875297808
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00555556	0.12990147875297808
#613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	0.00555556	0.12990147875297808
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00555556	0.12990147875297808
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00555556	0.12990147875297808
PYLE DISEASE; PYL	0.00555556	0.12990147875297808
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.00555556	0.12990147875297808
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00555556	0.12990147875297808
GLYCOGEN STORAGE DISEASE V; GSD5	0.00555556	0.12990147875297808
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00555556	0.12990147875297808
SANDHOFF DISEASE	0.00555556	0.12990147875297808
GLYCOGEN STORAGE DISEASE VII	0.00555556	0.12990147875297808
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.00555556	0.12990147875297808
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00555556	0.12990147875297808
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00555556	0.12990147875297808
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00555556	0.12990147875297808
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00555556	0.12990147875297808
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00555556	0.12990147875297808
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00555556	0.12990147875297808
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00555556	0.12990147875297808
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00555556	0.12990147875297808
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00555556	0.12990147875297808
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.00555556	0.12990147875297808
#613954 AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS14	0.00555556	0.12990147875297808
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00555556	0.12990147875297808
GLYCOGEN STORAGE DISEASE IXB	0.00555556	0.12990147875297808
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00555556	0.12990147875297808
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00555556	0.12990147875297808
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.005539435	0.12952444001252855
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.005538721999999999	0.1295077684700826
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.005538721999999999	0.1295077684700826
ROIFMAN-CHITAYAT SYNDROME	0.005538721999999999	0.1295077684700826
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00549492	0.12848357926641316
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00549492	0.12848357926641316
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.005477816	0.12808364930569077
SHUKLA-VERNON SYNDROME; SHUVER	0.0054771030000000005	0.12806697776324485
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.005477103	0.12806697776324483
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.005475805	0.12803662760602913
DYSTONIA 28, CHILDHOOD-ONSET	0.005475091999999999	0.12801995606358316
HAREL-YOON SYNDROME; HAYOS	0.005405947	0.12640319056228816
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.005405947	0.12640319056228816
CARDIAC LIPIDOSIS, FAMILIAL	0.00535714	0.12526197321003266
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.005344576	0.12496819865282285
DESANTO-SHINAWI SYNDROME	0.005343863	0.12495152711037694
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005343863	0.12495152711037694
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.005135161	0.12007160529894767
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.005135161	0.12007160529894767
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.005135161	0.12007160529894767
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.005135161	0.12007160529894767
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.005135161	0.12007160529894767
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.005116046	0.11962465363856362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005116046	0.11962465363856362
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.005115333	0.1196079820961177
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.005064005	0.11840781809799097
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.005063292	0.11839114655554504
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005063292	0.11839114655554504
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005063292	0.11839114655554504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.0050441769999999995	0.117944194895161
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0050441769999999995	0.117944194895161
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0050441769999999995	0.117944194895161
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0050441769999999995	0.117944194895161
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0050441769999999995	0.117944194895161
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.004997381	0.11684999924256716
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004997381	0.11684999924256716
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.004926225	0.11518621204161046
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.004926225	0.11518621204161046
OCULORENOCEREBELLAR SYNDROME	0.004926225	0.11518621204161046
FETAL IODINE DEFICIENCY DISORDER	0.004926225	0.11518621204161046
HOOFT DISEASE	0.004926225	0.11518621204161046
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.004926225	0.11518621204161046
PSEUDOURIDINURIA AND MENTAL DEFECT	0.004926225	0.11518621204161046
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.004926225	0.11518621204161046
CEPHALIN LIPIDOSIS	0.004926225	0.11518621204161046
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.004926225	0.11518621204161046
PENDRED SYNDROME	0.004926225	0.11518621204161046
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.004926225	0.11518621204161046
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.004926225	0.11518621204161046
T-SUBSTANCE ANOMALY	0.004926225	0.11518621204161046
DERMATOLEUKODYSTROPHY	0.004926225	0.11518621204161046
CONE-ROD DYSTROPHY 1; CORD1	0.004926225	0.11518621204161046
GLUTATHIONURIA	0.004926225	0.11518621204161046
LARSEN-LIKE SYNDROME	0.004925512	0.11516954049916453
#170100 PROLIDASE DEFICIENCY	0.004925512	0.11516954049916453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0048597399999999995	0.11363164331858493
MACROCEPHALY, BENIGN FAMILIAL	0.00469484	0.10977591071082511
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00469484	0.10977591071082511
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00469484	0.10977591071082511
COLOBOMA, OCULAR	0.00469484	0.10977591071082511
CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1	0.00469484	0.10977591071082511
Orofaciodigital syndrome XVII	0.00469484	0.10977591071082511
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.004633221	0.10833512000398733
HUNTINGTON DISEASE; HD	0.004633221	0.10833512000398733
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.004633221	0.10833512000398733
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00463121	0.10828809830432569
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00463121	0.10828809830432569
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00463121	0.10828809830432569
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00463121	0.10828809830432569
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00463121	0.10828809830432569
MEIER-GORLIN SYNDROME 3; MGORS3	0.00463121	0.10828809830432569
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00463121	0.10828809830432569
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.004562065	0.10667133280303065
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.004561352	0.10665466126058473
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.004561352	0.10665466126058473
SPINOCEREBELLAR ATAXIA 5; SCA5	0.004561352	0.10665466126058473
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.004561352	0.10665466126058473
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.004561352	0.10665466126058473
PEROXISOME BIOGENESIS DISORDER 5B	0.004561352	0.10665466126058473
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.004561352	0.10665466126058473
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004499981	0.10521966935111943
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.004499981	0.10521966935111943
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004499981	0.10521966935111943
CHROMOSOME 13q14 DELETION SYNDROME	0.004428825	0.10355588215016273
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.004428825	0.10355588215016273
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.004428112	0.10353921060771681
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.004428112	0.10353921060771681
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004428112	0.10353921060771681
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.004271451	0.09987612433686019
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00421941	0.09865928879628755
CARDIAC-UROGENITAL SYNDROME; CUGS	0.004200295	0.0982123371359035
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.004200295	0.0982123371359035
DESBUQUOIS DYSPLASIA 1	0.004200295	0.0982123371359035
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.004200295	0.0982123371359035
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.004200295	0.0982123371359035
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.004200295	0.0982123371359035
MENTAL RETARDATION, X-LINKED 97; MRX97	0.004200295	0.0982123371359035
MENTAL RETARDATION, X-LINKED 19	0.004200295	0.0982123371359035
NOONAN SYNDROME 6; NS6	0.0041995819999999994	0.09819566559345758
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0041995819999999994	0.09819566559345758
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0041995819999999994	0.09819566559345758
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0041995819999999994	0.09819566559345758
SAUL-WILSON SYNDROME; SWILS	0.0041995819999999994	0.09819566559345758
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.0041995819999999994	0.09819566559345758
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.09543768273990703
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.09543768273990703
ALAND ISLAND EYE DISEASE	0.00408163	0.09543768273990703
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.09543768273990703
AREDYLD	0.00408163	0.09543768273990703
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.09543768273990703
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.09543768273990703
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.09543768273990703
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.09543768273990703
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.09543768273990703
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.09543768273990703
BEETURIA	0.00408163	0.09543768273990703
GLOMUVENOUS MALFORMATIONS	0.00408163	0.09543768273990703
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.09543768273990703
ONCOCYTOMA	0.00408163	0.09543768273990703
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.09543768273990703
FLOOD FACTOR DEFICIENCY	0.00408163	0.09543768273990703
XM SYSTEM	0.00408163	0.09543768273990703
LIPASE DEFICIENCY, COMBINED	0.00408163	0.09543768273990703
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.09543768273990703
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.09543768273990703
TRISOMY 18-LIKE SYNDROME	0.00408163	0.09543768273990703
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.09543768273990703
PERRY SYNDROME	0.00408163	0.09543768273990703
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.09543768273990703
ICHTHYOSIS, X-LINKED	0.00408163	0.09543768273990703
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.09543768273990703
FINGERPRINT BODY MYOPATHY	0.00408163	0.09543768273990703
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.09543768273990703
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.09543768273990703
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.09543768273990703
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.09543768273990703
DELETED IN AZOOSPERMIA	0.00408163	0.09543768273990703
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00408163	0.09543768273990703
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.09543768273990703
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.09543768273990703
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.09543768273990703
HYPERPROGLUCAGONEMIA	0.00408163	0.09543768273990703
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.09543768273990703
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.09543768273990703
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.09543768273990703
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.09543768273990703
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.09543768273990703
ZINC, ELEVATED PLASMA	0.00408163	0.09543768273990703
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.09543768273990703
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.09543768273990703
MACROCYTOSIS, FAMILIAL	0.00408163	0.09543768273990703
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.09543768273990703
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.09543768273990703
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.09543768273990703
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.09543768273990703
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.09543768273990703
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.09543768273990703
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.09543768273990703
GONADOBLASTOMA	0.00408163	0.09543768273990703
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.09543768273990703
LYMPHOKINE DEFICIENCY	0.00408163	0.09543768273990703
XANTHINURIA, TYPE I	0.00408163	0.09543768273990703
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.09543768273990703
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.09543768273990703
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.09543768273990703
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.09543768273990703
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.09543768273990703
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.09543768273990703
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.09543768273990703
ALKAPTONURIA	0.00408163	0.09543768273990703
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.09543768273990703
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.09543768273990703
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.09543768273990703
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.09543768273990703
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.09543768273990703
SCHIZOPHRENIA 4	0.00408163	0.09543768273990703
APOLIPOPROTEIN(A)	0.00408163	0.09543768273990703
PYGMY	0.00408163	0.09543768273990703
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.09543768273990703
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.09543768273990703
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.09543768273990703
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.09543768273990703
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.09543768273990703
CALVARIAL HYPEROSTOSIS	0.00408163	0.09543768273990703
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.09543768273990703
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.09543768273990703
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.09543768273990703
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.09543768273990703
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.09543768273990703
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.09543768273990703
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.09543768273990703
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.09543768273990703
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.09543768273990703
ETHANOLAMINOSIS	0.00408163	0.09543768273990703
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.09543768273990703
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.09543768273990703
LARON SYNDROME	0.00408163	0.09543768273990703
ACETYLATION, SLOW	0.00408163	0.09543768273990703
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.09543768273990703
COUMARIN RESISTANCE	0.00408163	0.09543768273990703
HEINZ BODY ANEMIAS	0.00408163	0.09543768273990703
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.09543768273990703
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.09543768273990703
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.09543768273990703
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.09543768273990703
CARBOXYLESTERASE 1	0.00408163	0.09543768273990703
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.09543768273990703
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.09543768273990703
OSTEOGENIC SARCOMA	0.00408163	0.09543768273990703
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.09543768273990703
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.09543768273990703
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.09543768273990703
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.09543768273990703
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.09543768273990703
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.09543768273990703
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.09543768273990703
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.09543768273990703
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.09543768273990703
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.09543768273990703
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.09543768273990703
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.09543768273990703
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.09543768273990703
HYPOASCORBEMIA	0.00408163	0.09543768273990703
OVARIAN CANCER	0.00408163	0.09543768273990703
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.09543768273990703
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.09543768273990703
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.09543768273990703
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.09543768273990703
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.09543768273990703
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00408163	0.09543768273990703
GLUTATHIONE REDUCTASE	0.00408163	0.09543768273990703
PROGESTERONE RESISTANCE	0.00408163	0.09543768273990703
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.09543768273990703
PACMAN DYSPLASIA	0.00408163	0.09543768273990703
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.09543768273990703
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.09543768273990703
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.09543768273990703
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.09543768273990703
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.09543768273990703
PARAOXONASE 1	0.00408163	0.09543768273990703
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.09543768273990703
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.09543768273990703
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.09543768273990703
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.09543768273990703
CITRULLINE TRANSPORT DEFECT	0.00408163	0.09543768273990703
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.09543768273990703
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.09543768273990703
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.09543768273990703
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.09543768273990703
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.09543768273990703
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.09543768273990703
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.09543768273990703
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.09543768273990703
KABUKI SYNDROME 1	0.0038797380000000006	0.09071699403374668
CHROMOSOME 16p13.3 DELETION SYNDROME	0.0038797380000000006	0.09071699403374668
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0038797380000000006	0.09071699403374668
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0038797380000000006	0.09071699403374668
PELIZAEUS-MERZBACHER DISEASE	0.0038797380000000006	0.09071699403374668
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0038797380000000006	0.09071699403374668
GLASS SYNDROME	0.0038797380000000006	0.09071699403374668
CHROMOSOME 1p35 DELETION SYNDROME	0.0038797380000000006	0.09071699403374668
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0038797380000000006	0.09071699403374668
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0038797380000000006	0.09071699403374668
KBG SYNDROME	0.0038797380000000006	0.09071699403374668
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.003879738	0.09071699403374667
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.003879738	0.09071699403374667
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.003879738	0.09071699403374667
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003879738	0.09071699403374667
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.003879738	0.09071699403374667
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.003879738	0.09071699403374667
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.003879738	0.09071699403374667
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.003879738	0.09071699403374667
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.003879738	0.09071699403374667
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.003879738	0.09071699403374667
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.00371747	0.08692280350132721
#610246 SPINOCEREBELLAR ATAXIA 28; SCA28	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 14	0.00371747	0.08692280350132721
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 30; SCA30	0.00371747	0.08692280350132721
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00371747	0.08692280350132721
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.00371747	0.08692280350132721
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.00371747	0.08692280350132721
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.00371747	0.08692280350132721
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 26	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 31	0.00371747	0.08692280350132721
SCHOLTE SYNDROME; SHLTS	0.00371747	0.08692280350132721
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00371747	0.08692280350132721
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00371747	0.08692280350132721
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00371747	0.08692280350132721
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00371747	0.08692280350132721
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00371747	0.08692280350132721
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00371747	0.08692280350132721
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00371747	0.08692280350132721
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00371747	0.08692280350132721
SPINOCEREBELLAR ATAXIA 15	0.00371747	0.08692280350132721
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00371747	0.08692280350132721
#604432 SPINOCEREBELLAR ATAXIA 11; SCA11	0.00371747	0.08692280350132721
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00358423	0.0838073528484593
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00358423	0.0838073528484593
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0033556999999999997	0.07846380783420005
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0033556999999999997	0.07846380783420005
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.0033556999999999997	0.07846380783420005
MELNICK-NEEDLES SYNDROME	0.0033556999999999997	0.07846380783420005
FRANK-TER HAAR SYNDROME; FTHS	0.0033556999999999997	0.07846380783420005
260150 PALANT CLEFT PALATE SYNDROME	0.0033556999999999997	0.07846380783420005
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0033556999999999997	0.07846380783420005
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.0033556999999999997	0.07846380783420005
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0033556999999999997	0.07846380783420005
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0033556999999999997	0.07846380783420005
ODONTOCHONDRODYSPLASIA; ODCD	0.0033556999999999997	0.07846380783420005
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.0033556999999999997	0.07846380783420005
BARTH SYNDROME; BTHS	0.0033556999999999997	0.07846380783420005
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0033556999999999997	0.07846380783420005
#614869 USHER SYNDROME, TYPE IJ; USH1J	0.0033556999999999997	0.07846380783420005
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.0033556999999999997	0.07846380783420005
GLYCOGEN STORAGE DISEASE IXC	0.0033556999999999997	0.07846380783420005
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.0033556999999999997	0.07846380783420005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0033556999999999997	0.07846380783420005
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0033556999999999997	0.07846380783420005
Contractural arachnodactyly, congenital	0.0033556999999999997	0.07846380783420005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.0033556999999999997	0.07846380783420005
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0033556999999999997	0.07846380783420005
DYSTONIA 16; DYT16	0.0033556999999999997	0.07846380783420005
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.0033556999999999997	0.07846380783420005
Mulchandani-Bhoj-Conlin syndrome	0.0033556999999999997	0.07846380783420005
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0033556999999999997	0.07846380783420005
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0033556999999999997	0.07846380783420005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.0033556999999999997	0.07846380783420005
%614990 USHER SYNDROME, TYPE IK; USH1K	0.0033556999999999997	0.07846380783420005
OTOONYCHOPERONEAL SYNDROME	0.0033556999999999997	0.07846380783420005
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0033556999999999997	0.07846380783420005
#156550 KNIEST DYSPLASIA	0.0033556999999999997	0.07846380783420005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.0033556999999999997	0.07846380783420005
USHER SYNDROME, TYPE IF	0.0033556999999999997	0.07846380783420005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0033556999999999997	0.07846380783420005
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.0033556999999999997	0.07846380783420005
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0033556999999999997	0.07846380783420005
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.003035856	0.07098513627448916
INCONTINENTIA PIGMENTI; IP	0.003035856	0.07098513627448916
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.003035856	0.07098513627448916
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.003035856	0.07098513627448916
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.003035856	0.07098513627448916
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.003035856	0.07098513627448916
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.003035856	0.07098513627448916
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.003035856	0.07098513627448916
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.003035856	0.07098513627448916
Myhre syndrome	0.003035856	0.07098513627448916
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.003035856	0.07098513627448916
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.003035856	0.07098513627448916
Wolf-Hirschhorn Syndrome	0.003035856	0.07098513627448916
Angelman syndrome (Type 2)	0.003035856	0.07098513627448916
Angelman syndrome (Type 1)	0.003035856	0.07098513627448916
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.003035856	0.07098513627448916
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.0030351430000000006	0.07096846473204325
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.0030351430000000006	0.07096846473204325
C SYNDROME	0.0030351430000000006	0.07096846473204325
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0030351430000000006	0.07096846473204325
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0030351430000000006	0.07096846473204325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0030351430000000006	0.07096846473204325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.003035143	0.07096846473204324
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.003035143	0.07096846473204324
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.003035143	0.07096846473204324
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.003035143	0.07096846473204324
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.003035143	0.07096846473204324
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.003035143	0.07096846473204324
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.003035143	0.07096846473204324
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.003035143	0.07096846473204324
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.003035143	0.07096846473204324
TOWNES-BROCKS SYNDROME 1; TBS1	0.0029639870000000004	0.06930467753108656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0029639870000000004	0.06930467753108656
WARSAW BREAKAGE SYNDROME; WABS	0.0029639870000000004	0.06930467753108656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029639870000000004	0.06930467753108656
ALAZAMI-YUAN SYNDROME	0.0029639870000000004	0.06930467753108656
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0029639870000000004	0.06930467753108656
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0029639870000000004	0.06930467753108656
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.0029639870000000004	0.06930467753108656
BETA-UREIDOPROPIONASE DEFICIENCY	0.0029639870000000004	0.06930467753108656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.0029639870000000004	0.06930467753108656
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0029639870000000004	0.06930467753108656
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0029639870000000004	0.06930467753108656
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0029639870000000004	0.06930467753108656
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0029639870000000004	0.06930467753108656
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0029639870000000004	0.06930467753108656
RING CHROMOSOME 14 SYNDROME	0.0029639870000000004	0.06930467753108656
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0029639870000000004	0.06930467753108656
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029639870000000004	0.06930467753108656
SECKEL SYNDROME 8; SCKL8	0.0029639870000000004	0.06930467753108656
#614728 SECKEL SYNDROME 6; SCKL6	0.0029639870000000004	0.06930467753108656
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0029639870000000004	0.06930467753108656
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0029639870000000004	0.06930467753108656
LOWRY-MACLEAN SYNDROME	0.0029639870000000004	0.06930467753108656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0029639870000000004	0.06930467753108656
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0029639870000000004	0.06930467753108656
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0029639870000000004	0.06930467753108656
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0029639870000000004	0.06930467753108656
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0029639870000000004	0.06930467753108656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002604228	0.06089270356362106
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002604228	0.06089270356362106
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002604228	0.06089270356362106
Muenke syndrome	0.002604228	0.06089270356362106
CHROMOSOME 5Q12 DELETION SYNDROME	0.002604228	0.06089270356362106
IMMUNODEFICIENCY 49; IMD49	0.002604228	0.06089270356362106
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002604228	0.06089270356362106
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002604228	0.06089270356362106
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002604228	0.06089270356362106
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.002604228	0.06089270356362106
LEIGH SYNDROME; LS	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.002604228	0.06089270356362106
CHROMOSOME 16p13.2 DELETION SYNDROME	0.002604228	0.06089270356362106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002604228	0.06089270356362106
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002604228	0.06089270356362106
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.002604228	0.06089270356362106
GRISCELLI SYNDROME, TYPE 1	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.002604228	0.06089270356362106
ELEJALDE DISEASE	0.002604228	0.06089270356362106
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002604228	0.06089270356362106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002604228	0.06089270356362106
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.002604228	0.06089270356362106
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.002604228	0.06089270356362106
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.002604228	0.06089270356362106
Cerebral creatine deficiency syndrome 2	0.002604228	0.06089270356362106
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002604228	0.06089270356362106
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.002604228	0.06089270356362106
MENTAL RETARDATION, X-LINKED 72	0.002604228	0.06089270356362106
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002604228	0.06089270356362106
HYPERPROLINEMIA, TYPE I	0.002604228	0.06089270356362106
MENTAL RETARDATION, X-LINKED 88	0.002604228	0.06089270356362106
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.002191261	0.051236606972785724
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002191261	0.051236606972785724
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002191261	0.051236606972785724
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.002191261	0.051236606972785724
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.002191261	0.051236606972785724
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.002191261	0.051236606972785724
PERRAULT SYNDROME 3	0.002191261	0.051236606972785724
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.002191261	0.051236606972785724
KLEEFSTRA SYNDROME	0.002191261	0.051236606972785724
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.002120105	0.04957281977182905
MEIER-GORLIN SYNDROME 1; MGORS1	0.002120105	0.04957281977182905
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.002120105	0.04957281977182905
LARYNGEAL ABDUCTOR PARALYSIS	0.002120105	0.04957281977182905
207790 ARACHNOID CYSTS, INTRACRANIAL	0.002120105	0.04957281977182905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.002120105	0.04957281977182905
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.002120105	0.04957281977182905
VELOCARDIOFACIAL SYNDROME	0.002120105	0.04957281977182905
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.002120105	0.04957281977182905
MICROCEPHALY-CARDIOMYOPATHY	0.002120105	0.04957281977182905
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.002120105	0.04957281977182905
FANCONI ANEMIA	0.002120105	0.04957281977182905
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.002120105	0.04957281977182905
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.002120105	0.04957281977182905
CHROMOSOME Xp11.3 DELETION SYNDROME	0.002120105	0.04957281977182905
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.002120105	0.04957281977182905
#615328 SHAHEEN SYNDROME; SHNS	0.002120105	0.04957281977182905
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.002120105	0.04957281977182905
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.002120105	0.04957281977182905
GERODERMA OSTEODYSPLASTICUM; GO	0.002120105	0.04957281977182905
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.002120105	0.04957281977182905
15q24 recurrent microdeletion syndrome	0.002120105	0.04957281977182905
MENTAL RETARDATION, X-LINKED 63	0.002120105	0.04957281977182905
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.002120105	0.04957281977182905
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.002120105	0.04957281977182905
FACIOCARDIOMELIC SYNDROME	0.002120105	0.04957281977182905
9q subtelomeric deletion syndrome	0.002120105	0.04957281977182905
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.002120105	0.04957281977182905
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.002120105	0.04957281977182905
JOHANSON-BLIZZARD SYNDROME; JBS	0.002120105	0.04957281977182905
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.002120105	0.04957281977182905
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.002120105	0.04957281977182905
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.002120105	0.04957281977182905
RUVALCABA SYNDROME	0.002120105	0.04957281977182905
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.002120105	0.04957281977182905
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.002120105	0.04957281977182905
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.002120105	0.04957281977182905
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.002120105	0.04957281977182905
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.002120105	0.04957281977182905
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.002120105	0.04957281977182905
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.002120105	0.04957281977182905
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.002120105	0.04957281977182905
Cri du Chat Syndrome (5p deletion)	0.002120105	0.04957281977182905
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.002120105	0.04957281977182905
NIJMEGEN BREAKAGE SYNDROME	0.002120105	0.04957281977182905
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.002120105	0.04957281977182905
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.002120105	0.04957281977182905
2p15-16.1 microdeletion syndrome	0.002120105	0.04957281977182905
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.002120105	0.04957281977182905
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.002120105	0.04957281977182905
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.002120105	0.04957281977182905
COFFIN-SIRIS SYNDROME 10; CSS10	0.002120105	0.04957281977182905
FEINGOLD SYNDROME 2; FGLDS2	0.002120105	0.04957281977182905
ACHALASIA-MICROCEPHALY SYNDROME	0.002120105	0.04957281977182905
OCULOPALATOCEREBRAL SYNDROME	0.002120105	0.04957281977182905
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.002120105	0.04957281977182905
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.002120105	0.04957281977182905
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.002120105	0.04957281977182905
BARDET-BIEDL SYNDROME 20	0.002120105	0.04957281977182905
FEINGOLD SYNDROME 1; FGLDS1	0.002120105	0.04957281977182905
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.002120105	0.04957281977182905
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.002120105	0.04957281977182905
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0021193920000000003	0.04955614822938313
AL-RAQAD SYNDROME; ARS	0.0021193920000000003	0.04955614822938313
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0021193920000000003	0.04955614822938313
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0021193920000000003	0.04955614822938313
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0021193920000000003	0.04955614822938313
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.0021193920000000003	0.04955614822938313
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0021193920000000003	0.04955614822938313
FORSYTHE-WAKELING SYNDROME; FWS	0.0021193920000000003	0.04955614822938313
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021193920000000003	0.04955614822938313
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021193920000000003	0.04955614822938313
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0021193920000000003	0.04955614822938313
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0021193920000000003	0.04955614822938313
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.0021193920000000003	0.04955614822938313
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0021193920000000003	0.04955614822938313
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0021193920000000003	0.04955614822938313
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0021193920000000003	0.04955614822938313
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0021193920000000003	0.04955614822938313
ADAMS-OLIVER SYNDROME 3; AOS3	0.0021193920000000003	0.04955614822938313
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0021193920000000003	0.04955614822938313
Leukotriene C4 synthase deficiency	0.0021193920000000003	0.04955614822938313
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0021193920000000003	0.04955614822938313
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.0021193920000000003	0.04955614822938313
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0021193920000000003	0.04955614822938313
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.0021193920000000003	0.04955614822938313
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0021193920000000003	0.04955614822938313
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0021193920000000003	0.04955614822938313
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0021193920000000003	0.04955614822938313
LIG4 SYNDROME	0.0021193920000000003	0.04955614822938313
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0021193920000000003	0.04955614822938313
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0021193920000000003	0.04955614822938313
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0021193920000000003	0.04955614822938313
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0021193920000000003	0.04955614822938313
BARATELA-SCOTT SYNDROME	0.0021193920000000003	0.04955614822938313
ALAZAMI SYNDROME; ALAZS	0.0021193920000000003	0.04955614822938313
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.0021193920000000003	0.04955614822938313
224250 DYSMYELINATION WITH JAUNDICE	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, X-LINKED 82	0.0017603459999999999	0.04116084580436354
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.0017603459999999999	0.04116084580436354
HYPERLYSINEMIA, TYPE I	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0017603459999999999	0.04116084580436354
COWDEN SYNDROME 5; CWS5	0.0017603459999999999	0.04116084580436354
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.0017603459999999999	0.04116084580436354
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0017603459999999999	0.04116084580436354
RAMON SYNDROME	0.0017603459999999999	0.04116084580436354
IMMUNODEFICIENCY 47	0.0017603459999999999	0.04116084580436354
HYPERPROLINEMIA, TYPE II	0.0017603459999999999	0.04116084580436354
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.0017603459999999999	0.04116084580436354
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.0017603459999999999	0.04116084580436354
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.0017603459999999999	0.04116084580436354
KIFAFA SEIZURE DISORDER	0.0017603459999999999	0.04116084580436354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0017603459999999999	0.04116084580436354
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.0017603459999999999	0.04116084580436354
OHDO SYNDROME	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.0017603459999999999	0.04116084580436354
CLARK-BARAITSER SYNDROME	0.0017603459999999999	0.04116084580436354
DYSOSTEOSCLEROSIS	0.0017603459999999999	0.04116084580436354
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.0017603459999999999	0.04116084580436354
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0017603459999999999	0.04116084580436354
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0017603459999999999	0.04116084580436354
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.0017603459999999999	0.04116084580436354
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.0017603459999999999	0.04116084580436354
#613707 LEOPARD SYNDROME 3; LPRD3	0.0017603459999999999	0.04116084580436354
COWDEN SYNDROME 6; CWS6	0.0017603459999999999	0.04116084580436354
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.0017603459999999999	0.04116084580436354
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0017603459999999999	0.04116084580436354
FOUNTAIN SYNDROME	0.0017603459999999999	0.04116084580436354
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, FRA12A TYPE	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.0017603459999999999	0.04116084580436354
GURRIERI SYNDROME	0.0017603459999999999	0.04116084580436354
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.0017603459999999999	0.04116084580436354
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.0017603459999999999	0.04116084580436354
1p36 microdeletion syndrome	0.0017603459999999999	0.04116084580436354
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0017603459999999999	0.04116084580436354
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.0017603459999999999	0.04116084580436354
SJOGREN-LARSSON SYNDROME; SLS	0.0017603459999999999	0.04116084580436354
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0017603459999999999	0.04116084580436354
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0017603459999999999	0.04116084580436354
CROUZON SYNDROME	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, X-LINKED 96; MRX96	0.0017603459999999999	0.04116084580436354
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.0017603459999999999	0.04116084580436354
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0017603459999999999	0.04116084580436354
AUTISM, SUSCEPTIBILITY TO, 18	0.0017603459999999999	0.04116084580436354
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.0017603459999999999	0.04116084580436354
POTOCKI-SHAFFER SYNDROME	0.0017603459999999999	0.04116084580436354
NOONAN SYNDROME 7; NS7	0.0017603459999999999	0.04116084580436354
AUTISM	0.0017603459999999999	0.04116084580436354
15q13.3 microdeletion syndrome	0.0017603459999999999	0.04116084580436354
MENTAL RETARDATION, X-LINKED 100	0.0017603459999999999	0.04116084580436354
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0017603459999999999	0.04116084580436354
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.041144174261917625
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.041144174261917625
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.041144174261917625
DIGEORGE SYNDROME; DGS	0.001759633	0.041144174261917625
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.041144174261917625
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.041144174261917625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.041144174261917625
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.041144174261917625
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.041144174261917625
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.041144174261917625
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.041144174261917625
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.041144174261917625
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.041144174261917625
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.041144174261917625
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.041144174261917625
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.041144174261917625
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.041144174261917625
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.041144174261917625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.041144174261917625
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.041144174261917625
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.041144174261917625
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.041144174261917625
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001759633	0.041144174261917625
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.041144174261917625
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.041144174261917625
SULFOCYSTEINURIA	0.001759633	0.041144174261917625
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.041144174261917625
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.041144174261917625
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.041144174261917625
HARTNUP DISORDER	0.001759633	0.041144174261917625
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.041144174261917625
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.041144174261917625
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001759633	0.041144174261917625
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001759633	0.041144174261917625
SCHINDLER DISEASE, TYPE I	0.001759633	0.041144174261917625
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.041144174261917625
BARDET-BIEDL SYNDROME 13; BBS13	0.0016884769999999999	0.039480387060960936
CHROMOSOME 15Q14 DELETION SYNDROME	0.0016884769999999999	0.039480387060960936
RICHARDS-RUNDLE SYNDROME; RRNS	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.0016884769999999999	0.039480387060960936
LAMB-SHAFFER SYNDROME	0.0016884769999999999	0.039480387060960936
CHROMOSOME 9P DELETION SYNDROME	0.0016884769999999999	0.039480387060960936
NOONAN SYNDROME 5; NS5	0.0016884769999999999	0.039480387060960936
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0016884769999999999	0.039480387060960936
CHROMOSOME 18P DELETION SYNDROME	0.0016884769999999999	0.039480387060960936
Bardet-Biedl syndrome 2	0.0016884769999999999	0.039480387060960936
CREE MENTAL RETARDATION SYNDROME	0.0016884769999999999	0.039480387060960936
BARDET-BIEDL SYNDROME 3; BBS3	0.0016884769999999999	0.039480387060960936
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0016884769999999999	0.039480387060960936
BARDET-BIEDL SYNDROME 14; BBS14	0.0016884769999999999	0.039480387060960936
IMMUNODEFICIENCY 23; IMD23	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0016884769999999999	0.039480387060960936
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, X-LINKED 99	0.0016884769999999999	0.039480387060960936
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.0016884769999999999	0.039480387060960936
CHOPS SYNDROME; CHOPS	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, X-LINKED 107; MRX107	0.0016884769999999999	0.039480387060960936
BARDET-BIEDL SYNDROME 16; BBS16	0.0016884769999999999	0.039480387060960936
MACROCEPHALY/AUTISM SYNDROME	0.0016884769999999999	0.039480387060960936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.0016884769999999999	0.039480387060960936
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0016884769999999999	0.039480387060960936
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.0016884769999999999	0.039480387060960936
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0016884769999999999	0.039480387060960936
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.0016884769999999999	0.039480387060960936
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0016884769999999999	0.039480387060960936
ELSAHY-WATERS SYNDROME; ESWS	0.0016884769999999999	0.039480387060960936
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.0016884769999999999	0.039480387060960936
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.0016884769999999999	0.039480387060960936
JOUBERT SYNDROME 28	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.0016884769999999999	0.039480387060960936
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0016884769999999999	0.039480387060960936
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.0016884769999999999	0.039480387060960936
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.0016884769999999999	0.039480387060960936
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.0016884769999999999	0.039480387060960936
3MC SYNDROME 2	0.0016884769999999999	0.039480387060960936
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0016884769999999999	0.039480387060960936
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.0016884769999999999	0.039480387060960936
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.0016884769999999999	0.039480387060960936
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.0016884769999999999	0.039480387060960936
PEROXISOME BIOGENESIS DISORDER 3B	0.0016884769999999999	0.039480387060960936
BARDET-BIEDL SYNDROME 8; BBS8	0.0016884769999999999	0.039480387060960936
BARDET-BIEDL SYNDROME 1; BBS1	0.0016884769999999999	0.039480387060960936
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.0016884769999999999	0.039480387060960936
COHEN-GIBSON SYNDROME; COGIS	0.0016884769999999999	0.039480387060960936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.0016884769999999999	0.039480387060960936
RAHMAN SYNDROME	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0016884769999999999	0.039480387060960936
AU-KLINE SYNDROME; AUKS	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.0016884769999999999	0.039480387060960936
MENTAL RETARDATION, X-LINKED 41	0.0016884769999999999	0.039480387060960936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.0016884769999999999	0.039480387060960936
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0016884769999999999	0.039480387060960936
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0016884769999999999	0.039480387060960936
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00127551	0.02982429047012562
MEIER-GORLIN SYNDROME 8; MGORS8	0.00127551	0.02982429047012562
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00127551	0.02982429047012562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00127551	0.02982429047012562
RHIZOMELIC SYNDROME	0.00127551	0.02982429047012562
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00127551	0.02982429047012562
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00127551	0.02982429047012562
SAY SYNDROME	0.00127551	0.02982429047012562
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00127551	0.02982429047012562
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00127551	0.02982429047012562
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.00127551	0.02982429047012562
NEU-LAXOVA SYNDROME 2; NLS2	0.00127551	0.02982429047012562
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.02982429047012562
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00127551	0.02982429047012562
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00127551	0.02982429047012562
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00127551	0.02982429047012562
VERVERI-BRADY SYNDROME; VERBRAS	0.00127551	0.02982429047012562
TEEBI-SHALTOUT SYNDROME; TBSH	0.00127551	0.02982429047012562
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00127551	0.02982429047012562
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00127551	0.02982429047012562
SECKEL SYNDROME 4	0.00127551	0.02982429047012562
3MC SYNDROME 1	0.00127551	0.02982429047012562
MEIER-GORLIN SYNDROME 2; MGORS2	0.00127551	0.02982429047012562
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00127551	0.02982429047012562
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00127551	0.02982429047012562
BLOOM SYNDROME	0.00127551	0.02982429047012562
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00127551	0.02982429047012562
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00127551	0.02982429047012562
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00127551	0.02982429047012562
#614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8	0.00127551	0.02982429047012562
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00127551	0.02982429047012562
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00127551	0.02982429047012562
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00127551	0.02982429047012562
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00127551	0.02982429047012562
HYPERREFLEXIA	0.00127551	0.02982429047012562
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00127551	0.02982429047012562
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00127551	0.02982429047012562
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00127551	0.02982429047012562
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00127551	0.02982429047012562
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00127551	0.02982429047012562
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00127551	0.02982429047012562
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00127551	0.02982429047012562
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.00127551	0.02982429047012562
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00127551	0.02982429047012562
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00127551	0.02982429047012562
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00127551	0.02982429047012562
MARTSOLF SYNDROME	0.00127551	0.02982429047012562
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00127551	0.02982429047012562
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00127551	0.02982429047012562
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00127551	0.02982429047012562
601453 TRICHODENTAL DYSPLASIA	0.00127551	0.02982429047012562
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00127551	0.02982429047012562
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00127551	0.02982429047012562
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00127551	0.02982429047012562
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00127551	0.02982429047012562
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00127551	0.02982429047012562
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00127551	0.02982429047012562
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00127551	0.02982429047012562
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00127551	0.02982429047012562
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00127551	0.02982429047012562
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00127551	0.02982429047012562
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00127551	0.02982429047012562
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00127551	0.02982429047012562
ADDUCTED THUMBS SYNDROME	0.00127551	0.02982429047012562
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00127551	0.02982429047012562
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00127551	0.02982429047012562
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.00127551	0.02982429047012562
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00127551	0.02982429047012562
BOWEN-CONRADI SYNDROME	0.00127551	0.02982429047012562
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00127551	0.02982429047012562
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00127551	0.02982429047012562
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00127551	0.02982429047012562
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.00127551	0.02982429047012562
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.021412316502660116
ATKIN-FLAITZ SYNDROME	0.000915751	0.021412316502660116
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.021412316502660116
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.021412316502660116
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.021412316502660116
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.021412316502660116
DIAMINOPENTANURIA	0.000915751	0.021412316502660116
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.021412316502660116
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.021412316502660116
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.021412316502660116
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.021412316502660116
CRANIOSYNOSTOSIS 2	0.000915751	0.021412316502660116
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.021412316502660116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.021412316502660116
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.021412316502660116
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000915751	0.021412316502660116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.021412316502660116
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.021412316502660116
PARIETAL FORAMINA	0.000915751	0.021412316502660116
THREONINEMIA	0.000915751	0.021412316502660116
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.021412316502660116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.021412316502660116
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.021412316502660116
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.021412316502660116
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000915751	0.021412316502660116
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.021412316502660116
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.021412316502660116
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.021412316502660116
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.021412316502660116
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.021412316502660116
ZIMMERMANN-LABAND SYNDROME 1	0.000915751	0.021412316502660116
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.021412316502660116
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.021412316502660116
KUFOR-RAKEB SYNDROME	0.000915751	0.021412316502660116
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.021412316502660116
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.021412316502660116
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.021412316502660116
DARIER-WHITE DISEASE; DAR	0.000915751	0.021412316502660116
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.021412316502660116
HYPER-BETA-ALANINEMIA	0.000915751	0.021412316502660116
FLYNN-AIRD SYNDROME	0.000915751	0.021412316502660116
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.021412316502660116
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.021412316502660116
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.021412316502660116
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.021412316502660116
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000915751	0.021412316502660116
THYROCEREBRORETINAL SYNDROME	0.000915751	0.021412316502660116
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.021412316502660116
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.021412316502660116
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.021412316502660116
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.021412316502660116
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.021412316502660116
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.021412316502660116
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.021412316502660116
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.021412316502660116
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.021412316502660116
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.021412316502660116
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.021412316502660116
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.021412316502660116
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.021412316502660116
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.021412316502660116
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.021412316502660116
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.021412316502660116
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.021412316502660116
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.021412316502660116
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.021412316502660116
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000915751	0.021412316502660116
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.021412316502660116
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.021412316502660116
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.021412316502660116
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.021412316502660116
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.021412316502660116
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.021412316502660116
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.021412316502660116
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.021412316502660116
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.021412316502660116
EPILEPSY, READING	0.000915751	0.021412316502660116
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.021412316502660116
WAGR 11p13 deletion syndrome	0.000844595	0.01974852930170343
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.000844595	0.01974852930170343
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.000844595	0.01974852930170343
Prader-Willi syndrome (Type 1)	0.000844595	0.01974852930170343
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.000844595	0.01974852930170343
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000844595	0.01974852930170343
3q29 microdeletion syndrome	0.000844595	0.01974852930170343
SACCHAROPINURIA	0.000844595	0.01974852930170343
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 92	0.000844595	0.01974852930170343
Potocki-Shaffer syndrome	0.000844595	0.01974852930170343
SCARF SYNDROME	0.000844595	0.01974852930170343
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000844595	0.01974852930170343
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000844595	0.01974852930170343
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000844595	0.01974852930170343
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000844595	0.01974852930170343
OROFACIODIGITAL SYNDROME XI; OFD11	0.000844595	0.01974852930170343
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.000844595	0.01974852930170343
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000844595	0.01974852930170343
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.000844595	0.01974852930170343
22q11 duplication syndrome	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000844595	0.01974852930170343
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.000844595	0.01974852930170343
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000844595	0.01974852930170343
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.000844595	0.01974852930170343
BARDET-BIEDL SYNDROME 4; BBS4	0.000844595	0.01974852930170343
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 95	0.000844595	0.01974852930170343
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.000844595	0.01974852930170343
THUMB DEFORMITY AND ALOPECIA	0.000844595	0.01974852930170343
#611090 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12	0.000844595	0.01974852930170343
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000844595	0.01974852930170343
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000844595	0.01974852930170343
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000844595	0.01974852930170343
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000844595	0.01974852930170343
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000844595	0.01974852930170343
601095 HARROD SYNDROME	0.000844595	0.01974852930170343
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.000844595	0.01974852930170343
245800 LAURENCE-MOON SYNDROME	0.000844595	0.01974852930170343
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.000844595	0.01974852930170343
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000844595	0.01974852930170343
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000844595	0.01974852930170343
Sotos syndrome	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 53	0.000844595	0.01974852930170343
2q37 monosomy	0.000844595	0.01974852930170343
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000844595	0.01974852930170343
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.000844595	0.01974852930170343
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.000844595	0.01974852930170343
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000844595	0.01974852930170343
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.000844595	0.01974852930170343
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000844595	0.01974852930170343
8p23.1 deletion syndrome	0.000844595	0.01974852930170343
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.000844595	0.01974852930170343
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000844595	0.01974852930170343
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000844595	0.01974852930170343
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000844595	0.01974852930170343
OLIVER SYNDROME	0.000844595	0.01974852930170343
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.000844595	0.01974852930170343
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000844595	0.01974852930170343
RODRIGUES BLINDNESS	0.000844595	0.01974852930170343
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.000844595	0.01974852930170343
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000844595	0.01974852930170343
SOTOS SYNDROME 3	0.000844595	0.01974852930170343
22q11.2 distal deletion syndrome	0.000844595	0.01974852930170343
CARNOSINEMIA	0.000844595	0.01974852930170343
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000844595	0.01974852930170343
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000844595	0.01974852930170343
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.000844595	0.01974852930170343
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000844595	0.01974852930170343
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.000844595	0.01974852930170343
Rothmund-Thomson syndrome	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000844595	0.01974852930170343
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.000844595	0.01974852930170343
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 46	0.000844595	0.01974852930170343
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 84	0.000844595	0.01974852930170343
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000844595	0.01974852930170343
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.000844595	0.01974852930170343
Prader-Willi Syndrome (Type 2)	0.000844595	0.01974852930170343
OROFACIODIGITAL SYNDROME III	0.000844595	0.01974852930170343
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000844595	0.01974852930170343
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000844595	0.01974852930170343
FRONTOMETAPHYSEAL DYSPLASIA	0.000844595	0.01974852930170343
BARDET-BIEDL SYNDROME 19; BBS19	0.000844595	0.01974852930170343
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
GRANGE SYNDROME; GRNG	0.000844595	0.01974852930170343
#614249 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18	0.000844595	0.01974852930170343
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000844595	0.01974852930170343
ATR-16 syndrome	0.000844595	0.01974852930170343
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000844595	0.01974852930170343
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.000844595	0.01974852930170343
CHROMOSOME 17q12 DELETION SYNDROME	0.000844595	0.01974852930170343
HYDROXYPROLINEMIA	0.000844595	0.01974852930170343
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000844595	0.01974852930170343
#150250 LARSEN SYNDROME; LRS	0.000844595	0.01974852930170343
15q26 overgrowth syndrome	0.000844595	0.01974852930170343
MYOCLONIC-ATONIC EPILEPSY	0.000844595	0.01974852930170343
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.000844595	0.01974852930170343
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.000844595	0.01974852930170343
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000844595	0.01974852930170343
LAMBERT SYNDROME	0.000844595	0.01974852930170343
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000844595	0.01974852930170343
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000844595	0.01974852930170343
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.000844595	0.01974852930170343
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 2	0.000844595	0.01974852930170343
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000844595	0.01974852930170343
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.000844595	0.01974852930170343
MORQUIO SYNDROME C	0.000844595	0.01974852930170343
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000844595	0.01974852930170343
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000844595	0.01974852930170343
#611093 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 22; MRT22	0.000844595	0.01974852930170343
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.000844595	0.01974852930170343
BARDET-BIEDL SYNDROME 9; BBS9	0.000844595	0.01974852930170343
NOONAN SYNDROME 8; NS8	0.000844595	0.01974852930170343
TELECANTHUS	0.000844595	0.01974852930170343
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000844595	0.01974852930170343
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000844595	0.01974852930170343
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000844595	0.01974852930170343
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000844595	0.01974852930170343
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000844595	0.01974852930170343
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.000844595	0.01974852930170343
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.000844595	0.01974852930170343
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000844595	0.01974852930170343
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000844595	0.01974852930170343
DYSAUTONOMIA-LIKE DISORDER	0.000844595	0.01974852930170343
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.000844595	0.01974852930170343
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.000844595	0.01974852930170343
HOMOCARNOSINOSIS	0.000844595	0.01974852930170343
DICARBOXYLICAMINO ACIDURIA	0.000844595	0.01974852930170343
3MC SYNDROME 3	0.000844595	0.01974852930170343
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000844595	0.01974852930170343
N SYNDROME	0.000844595	0.01974852930170343
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
LEBER OPTIC ATROPHY AND DYSTONIA	0.000844595	0.01974852930170343
NF1-microdeletion syndrome	0.000844595	0.01974852930170343
KENNERKNECHT SYNDROME	0.000844595	0.01974852930170343
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000844595	0.01974852930170343
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.000844595	0.01974852930170343
TRYPTOPHANURIA WITH DWARFISM	0.000844595	0.01974852930170343
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.000844595	0.01974852930170343
TYROSINE TRANSAMINASE DEFICIENCY	0.000844595	0.01974852930170343
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 20	0.000844595	0.01974852930170343
MICROPHTHALMIA, SYNDROMIC 12	0.000844595	0.01974852930170343
MCDONOUGH SYNDROME	0.000844595	0.01974852930170343
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000844595	0.01974852930170343
Cat-Eye Syndrome (Type I)	0.000844595	0.01974852930170343
DIBASIC AMINO ACIDURIA I	0.000844595	0.01974852930170343
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.000844595	0.01974852930170343
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 23	0.000844595	0.01974852930170343
LYSINE MALABSORPTION SYNDROME	0.000844595	0.01974852930170343
7q11.23 duplication syndrome	0.000844595	0.01974852930170343
OSTEOPENIA AND SPARSE HAIR	0.000844595	0.01974852930170343
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000844595	0.01974852930170343
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000844595	0.01974852930170343
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.000844595	0.01974852930170343
8p23.1 duplication syndrome	0.000844595	0.01974852930170343
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.000844595	0.01974852930170343
BARDET-BIEDL SYNDROME 6; BBS6	0.000844595	0.01974852930170343
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000844595	0.01974852930170343
DEAFNESS AND MYOPIA; DFNMYP	0.000844595	0.01974852930170343
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000844595	0.01974852930170343
OPTIC ATROPHY 2	0.000844595	0.01974852930170343
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.000844595	0.01974852930170343
12q14 microdeletion syndrome	0.000844595	0.01974852930170343
SONODA SYNDROME	0.000844595	0.01974852930170343
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000844595	0.01974852930170343
CAHMR SYNDROME	0.000844595	0.01974852930170343
FORMIMINOTRANSFERASE DEFICIENCY	0.000844595	0.01974852930170343
17q21.31 recurrent microdeletion syndrome	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.000844595	0.01974852930170343
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000844595	0.01974852930170343
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000844595	0.01974852930170343
HYPOCHONDROPLASIA	0.000844595	0.01974852930170343
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.000844595	0.01974852930170343
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.000844595	0.01974852930170343
16p11.2-p12.2 microdeletion syndrome	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 81	0.000844595	0.01974852930170343
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.000844595	0.01974852930170343
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.000844595	0.01974852930170343
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.000844595	0.01974852930170343
MUCOLIPIDOSIS III ALPHA/BETA	0.000844595	0.01974852930170343
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000844595	0.01974852930170343
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000844595	0.01974852930170343
1q21.1 recurrent microduplication (possible susceptibility locus for neurodevelopmental disorders)	0.000844595	0.01974852930170343
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000844595	0.01974852930170343
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.000844595	0.01974852930170343
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000844595	0.01974852930170343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000844595	0.01974852930170343
KEIPERT SYNDROME; KPTS	0.000844595	0.01974852930170343
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.000844595	0.01974852930170343
IMINOGLYCINURIA	0.000844595	0.01974852930170343
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 77	0.000844595	0.01974852930170343
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000844595	0.01974852930170343
Williams-Beuren Syndrome (WBS)	0.000844595	0.01974852930170343
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.000844595	0.01974852930170343
MENTAL RETARDATION, X-LINKED 45	0.000844595	0.01974852930170343
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000844595	0.01974852930170343
CYSTEINE PEPTIDURIA	0.000844595	0.01974852930170343
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000844595	0.01974852930170343
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.000844595	0.01974852930170343
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000844595	0.01974852930170343
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.000844595	0.01974852930170343
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000844595	0.01974852930170343
METAPHYSEAL ACROSCYPHODYSPLASIA	0.000844595	0.01974852930170343
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000844595	0.01974852930170343
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000844595	0.01974852930170343
HYDROXYLYSINURIA	0.000844595	0.01974852930170343
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000844595	0.01974852930170343
BARDET-BIEDL SYNDROME 7; BBS7	0.000844595	0.01974852930170343
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.000844595	0.01974852930170343
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.01973185775925751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.01973185775925751
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.01973185775925751
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.01973185775925751
FRONTOOCULAR SYNDROME	0.000843882	0.01973185775925751
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.01973185775925751
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.01973185775925751
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.01973185775925751
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.01973185775925751
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.01973185775925751
SENIOR-LOKEN SYNDROME 9	0.000843882	0.01973185775925751
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.01973185775925751
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.01973185775925751
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.01973185775925751
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.01973185775925751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.01973185775925751
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.01973185775925751
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.01973185775925751
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.01973185775925751
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.01973185775925751
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.01973185775925751
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.01973185775925751
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.01973185775925751
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.01973185775925751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.01973185775925751
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.01973185775925751
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.01973185775925751
PELLAGRA-LIKE SYNDROME	0.000843882	0.01973185775925751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.01973185775925751
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.01973185775925751
#300555 DENT DISEASE 2	0.000843882	0.01973185775925751
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.01973185775925751
WAARDENBURG-SHAH SYNDROME	0.000843882	0.01973185775925751
CURRARINO SYNDROME	0.000843882	0.01973185775925751
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.01973185775925751
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.01973185775925751
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.01973185775925751
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.01973185775925751
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.01973185775925751
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.01973185775925751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.01973185775925751
NOONAN SYNDROME 3; NS3	0.000843882	0.01973185775925751
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.01973185775925751
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.01973185775925751
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.01973185775925751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.01973185775925751
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.01973185775925751
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.01973185775925751
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.01973185775925751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.01973185775925751
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.01973185775925751
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.01973185775925751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.01973185775925751
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.01973185775925751
STEEL SYNDROME; STLS	0.000843882	0.01973185775925751
CDAGS SYNDROME	0.000843882	0.01973185775925751
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.01973185775925751
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.01973185775925751
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.01973185775925751
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.01973185775925751
NOONAN SYNDROME 9; NS9	0.000843882	0.01973185775925751
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.01973185775925751
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.01973185775925751
CHAR SYNDROME	0.000843882	0.01973185775925751
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.01973185775925751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.01973185775925751
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.01973185775925751
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.01973185775925751
NOONAN SYNDROME 2; NS2	0.000843882	0.01973185775925751
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.01973185775925751
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.01973185775925751
OROTIC ACIDURIA	0.000843882	0.01973185775925751
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.01973185775925751
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.01973185775925751
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.01973185775925751
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000843882	0.01973185775925751
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.01973185775925751
Aarskog-Scott syndrome	0.000843882	0.01973185775925751
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.01973185775925751
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.01973185775925751
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.01973185775925751
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.01973185775925751
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.01973185775925751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.01973185775925751
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.01973185775925751
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.01973185775925751
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.01973185775925751
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.01973185775925751
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.01973185775925751
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.01973185775925751
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000843882	0.01973185775925751
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.01973185775925751
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.01973185775925751
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.01973185775925751
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.01973185775925751
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.01973185775925751
Temtamy preaxial brachydactyly syndrome	0.000843882	0.01973185775925751
AUSTRALIA ANTIGEN	0.000843882	0.01973185775925751
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.01973185775925751
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.01973185775925751
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.01973185775925751
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.01973185775925751
NOONAN SYNDROME 11; NS11	0.000843882	0.01973185775925751
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.01973185775925751
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.01973185775925751
FRIAS SYNDROME	0.000843882	0.01973185775925751
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.01973185775925751
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.01973185775925751
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.01973185775925751
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.01973185775925751
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.01973185775925751
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.01973185775925751
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.01973185775925751
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.01973185775925751
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.01973185775925751
